US20040197894A1 - Subtilase variants - Google Patents

Subtilase variants Download PDF

Info

Publication number
US20040197894A1
US20040197894A1 US10/481,723 US48172303A US2004197894A1 US 20040197894 A1 US20040197894 A1 US 20040197894A1 US 48172303 A US48172303 A US 48172303A US 2004197894 A1 US2004197894 A1 US 2004197894A1
Authority
US
United States
Prior art keywords
deletion
subtilase
variant
subtilisin
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/481,723
Other languages
English (en)
Inventor
Tina Fano
Claus von der Osten
Malene Kruger
Mads Norregaard-Madsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040197894(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Assigned to NOVOZYMES A/S reassignment NOVOZYMES A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NANO, TINA SEJERSGAARD, VON DER OSTEN, CLAUS, KRUGER, MALENE KAPPEN, NORREGAARD-MADSEN, MADS
Publication of US20040197894A1 publication Critical patent/US20040197894A1/en
Priority to US12/035,766 priority Critical patent/US20080167213A1/en
Priority to US13/038,717 priority patent/US20110152155A1/en
Priority to US13/872,191 priority patent/US8569035B2/en
Priority to US14/035,241 priority patent/US20140018283A1/en
Priority to US14/502,234 priority patent/US9528100B2/en
Priority to US15/355,435 priority patent/US10351837B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38609—Protease or amylase in solid compositions only
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10—Objects to be cleaned
    • C11D2111/12—Soft surfaces, e.g. textile
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10—Objects to be cleaned
    • C11D2111/14—Hard surfaces

Definitions

  • the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: Wash performance, thermal stability, storage stability or catalytic activity.
  • the variants of the invention are suitable for use in e.g. cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions.
  • the present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention. Further, the present invention relates to cleaning and detergent compositions comprising the variants of the invention.
  • Enzymes used in such formulations comprise proteases, lipases, amylases, cellulases, as well as other enzymes, or mixtures thereof.
  • Commercially most important enzymes are proteases.
  • proteases protein engineered variants of naturally occurring wild type proteases, e.g. DURAZYM® (Novo Nordisk A/S), RELASE® (Novo Nordisk A/S), MAXAPEM® (Gist-Brocades N.V.), PURAFECT® (Genencor International, Inc.).
  • protease variants are described in the art. A thorough list of prior art protease variants is given in WO 99/27082.
  • an object of the present invention is to provide improved subtilase variants for such purposes.
  • the present invention relates to a subtilase variant comprising at least one or more of the following alterations:
  • each position corresponds to a position of the amino acid sequence of subtilisin BPN′, shown in FIG. 1.
  • the present invention relates to an isolated polynucleotide encoding a subtilase variant of the invention.
  • the present invention relates to an expression vector comprising the isolated polynucleotide of the invention.
  • the present invention relates to a microbial host cell transformed with the expression vector of the invention.
  • the present invention relates to a method for producing a subtilase variant according to the invention, wherein a host according to the invention is cultured under conditions conducive to the expression and secretion of the variant, and the variant is recovered.
  • the present invention relates to a cleaning or detergent composition, preferably a laundry or dish wash composition, comprising the variant of the invention.
  • FIG. 1 shows an alignments between subtilisin BPN′ (a) (BASBPN) and subtilisin 309 (BLSAVI)(b).
  • a frame of reference is first defined by aligning the isolated or parent enzyme with subtilisin BPN′ (BASBPN).
  • Another method is to use known recognized alignments between subtilases, such as the alignment indicated in WO 91/00345. In most cases the differences will not be of any importance.
  • subtilisin 309 SEQ ID NO.4 has 6 deletions in positions 36, 58, 158, 162, 163, and 164 in comparison to BASBPN. These deletions are in FIG. 1 indicated by asterixes (*)
  • the notation G195E thus means a substitution of a glycine in position 195 with a glutamic acid.
  • the original amino acid residue may be any amino acid residue
  • a short hand notation may at times be used indicating only the position and substituted amino acid:
  • both the original amino acid(s) and substituted amino acid(s) may comprise any amino acid, then only the position is indicated, e.g.: 170.
  • 170Ser is thus meant to comprise e.g. both a Lys170Ser modification in BASBPN and Arg170 Ser modification in BLSAVI (cf. FIG. 1).
  • R170G, R170A, R170S, and R170T are identical to [0104] R170G, R170A, R170S, and R170T.
  • deletion of more than one amino acid residue such as the deletion of glycine and leucine in positions 195 and 196 will be designated
  • Tyr167 ⁇ Gly,Ala,Ser,Thr ⁇ +Arg170 ⁇ Gly,Ala,Ser,Thr ⁇ designates the following variants:
  • Enzymes cleaving the amide linkages in protein substrates are classified as proteases, or (interchangeably) peptidases (see Walsh, 1979 , Enzymatic Reaction Mechanisms . W.H. Freeman and Company, San Francisco, Chapter 3).
  • subtilase BPN′ subtilase BPN′
  • FIG. 1 or Siezen et al. Protein Engng. 4 (1991) 719-737.
  • a serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 “Principles of Biochemistry,” Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272).
  • the bacterial serine proteases have molecular weights in the 20,000 to 45,000 Dalton range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease.
  • subtilases A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al., Protein Engng. 4 (1991) 719-737 and Siezen et al. Protein Science 6 (1997) 501-523. They are defined by homology analysis of more than 170 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously often defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al. now is a subgroup of the subtilases. A wide variety of subtilases have been identified, and the amino acid sequence of a number of subtilases has been determined. For a more detailed description of such subtilases and their amino acid sequences reference is made to Siezen et al. (1997).
  • subtilisin 168 subtilisin 168
  • subtilisin BPN′ subtilisin BPN′
  • subtilisin Carlsberg ALCALASE®, NOVOZYMES A/S
  • subtilisin DY subtilisin DY
  • subtilases I-S2 or high alkaline subtilisins
  • Sub-group I-S2 proteases are described as highly alkaline subtilisins and comprises enzymes such as subtilisin PB92 (BAALKP) (MAXACAL®, Gist-Brocades Nev.), subtilisin 309 (SAVINASE®, NOVOZYMES A/S), subtilisin 147 (BLS147) (ESPERASE®, NOVOZYMES A/S), and alkaline elastase YaB (BSEYAB).
  • SAVINASE® is marketed by NOVOZYMES A/S. It is subtilisin 309 from B. Lentus and differs from BAALKP only in one position (N87S, see FIG. 1 herein). SAVINASE® has the amino acid sequence designated b) in FIG. 1.
  • parent subtilase describes a subtilase defined according to Siezen et al. (1991 and 1997). For further details see description of “SUBTILASES” immediately above.
  • a parent subtilase may also be a subtilase isolated from a natural source, wherein subsequent modifications have been made while retaining the characteristic of a subtilase.
  • a parent subtilase may also be a subtilase which has been prepared by the DNA shuffling technique, such as described by J. E. Ness et al., Nature Biotechnology, 17, 893-896 (1999).
  • subtilase may be termed “wild type subtilase”.
  • Gram-positive enzyme acronym Bacillus subtilis 168 subtilisin I168, apr BSS168 Bacillus amyloliquefaciens subtilisin BPN′ (NOVO) BASBPN Bacillus subtilis DY subtilisin DY BSSDY Bacillus licheniformis subtilisin Carlsberg BLSCAR Bacillus lentus subtilisin 309 BLSAVI Bacillus lentus subtilisin 147 BLS147 Bacillus alcalophilus PB92 subtilisin PB92 BAPB92 Bacillus YaB alkaline elastase YaB BYSYAB Thermoactinomyces vulgaris thermitase TVTHER
  • modification(s) used herein is defined to include chemical modification of a subtilase as well as genetic manipulation of the DNA encoding a subtilase.
  • the modification(s) can be replacement(s) of the amino acid side chain(s), substitution(s), deletion(s) and/or insertions in or at the amino acid(s) of interest.
  • subtilase variant or mutated subtilase means a subtilase that has been produced by an organism which is expressing a mutant gene derived from a parent microorganism which possessed an original or parent gene and which produced a corresponding parent enzyme, the parent gene having been mutated in order to produce the mutant gene from which said mutated subtilase protease is produced when expressed in a suitable host.
  • the GAP routine of the GCG package version 9.1 can be applied (infra) using the same settings.
  • the output from the routine is besides the amino acid alignment the calculation of the “Percent Identity” between the two sequences.
  • isolated when applied to a polynucleotide, denotes that the polynucleotide has been removed from its natural genetic milieu and is thus free of other extraneous or unwanted coding sequences, and is in a form suitable for use within genetically engineered protein production systems.
  • isolated molecules are those that are separated from their natural environment and include cDNA and genomic clones.
  • Isolated DNA molecules of the present invention are free of other genes with which they are ordinarily associated, but may include naturally occurring 5′ and 3′ untranslated regions such as promoters and terminators. The identification of associated regions will be evident to one of ordinary skill in the art (see for example, Dynan and Tijan, Nature 316:774-78, 1985).
  • the term “an isolated polynucleotide” may alternatively be termed “a cloned polynucleotide”.
  • isolated indicates that the protein has been removed from its native environment.
  • the isolated protein is substantially free of other proteins, particularly other homologous proteins (i.e. “homologous impurities” (see below)).
  • An isolated protein is more than 10% pure, preferably more than 20% pure, more preferably more than 30% pure, as determined by SDS-PAGE. Further it is preferred to provide the protein in a highly purified form, i.e., more than 40% pure, more than 60% pure, more than 80% pure, more preferably more than 95% pure, and most preferably more than 99% pure, as determined by SDS-PAGE.
  • isolated protein may alternatively be termed “purified protein”.
  • homologous impurities means any impurity (e.g. another polypeptide than the subtilase of the invention), which originate from the homologous cell where the subtilase of the invention is originally obtained from.
  • the term “obtained from” as used herein in connection with a specific microbial source means that the polynucleotide and/or subtilase produced by the specific source, or by a cell in which a gene from the source has been inserted.
  • substrate used in connection with a substrate for a protease should be interpreted in its broadest form as comprising a compound containing at least one peptide (amide) bond susceptible to hydrolysis by a subtilisin protease.
  • product used in connection with a product derived from a protease enzymatic reaction should, in the context of the present invention, be interpreted to include the products of a hydrolysis reaction involving a subtilase protease.
  • a product may be the substrate in a subsequent hydrolysis reaction.
  • wash performance is used as an enzyme's ability to remove proteinaceous or organic stains present on the object to be cleaned during e.g. wash or hard surface cleaning. See also the “Model Detergent Wash Performance Test” in Example 3 herein.
  • R variant is the reflectance (measured at 460 nm) of the test material after being treated with a subtilase variant as described in the “Model Detergent Wash Performance Test”
  • R parent is the reflectance (measured at 460 nm) of the test material after being treated with the corresponding parent subtilase as described in the “Model Detergent Wash Performance Test”.
  • FIG. 1 shows an alignment between subtilisin BPN′ (a) and Savinase® (b) using the GAP routine mentioned above.
  • the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: Wash performance, thermal stability, storage stability or catalytic activity.
  • variants which are contemplated as being part of the invention are such variants where, when compared to the wild-type subtilase, one or more amino acid residues has been substituted, deleted or inserted in at least one or more of the following positions:
  • the positions to be mutated are one or more of:
  • a subtilase variant of the first aspect of the invention may be a parent or wild-type subtilase identified and isolated from nature.
  • Such a parent wildtype subtilase may be specifically screened for by standard techniques known in the art.
  • One preferred way of doing this may be by specifically PCR amplify conserved DNA regions of interest from subtilases from numerous different microorganism, preferably different Bacillus strains.
  • Subtilases are a group of conserved enzymes, in the sense that their DNA and amino acid sequences are homologous. Accordingly it is possible to construct relatively specific primers flanking the polynucleotide sequences of interest.
  • subtilase variant of the invention is predominantly a variant of a parent subtilase.
  • a subtilase variant suitable for the uses described herein may be constructed by standard techniques known in the art such as by site-directed/random mutagenesis or by DNA shuffling of different subtilase sequences. See the “Material and Methods” section herein (vide infra) for further details.
  • variants described herein may comprise one or more further modifications, in particular one or more further substitutions.
  • variants described herein may encompass mutation at more than just one position.
  • the variant according to the invention may contain mutations at one position, two positions, or more than two positions, such as three, four or five positions.
  • subtilase variants comprising conservative substitutions are expected to exhibit characteristics that are not drastically different from each other.
  • subtilase variants Based on the disclosed and/or exemplified subtilase variants herein, it is routine work for a person skilled in the art to identify suitable conservative modification(s) to these variants in order to obtain other subtilase variants exhibiting similarly improved wash-performance.
  • the parent subtilase belongs to the subgroups I-S1 and I-S2, especially subgroup I-S2, both for enzymes from nature or from the artificial creation of diversity, and for designing and producing variants from a parent subtilase.
  • subtilase In relation to variants from subgroup I-S1, it is preferred to select a parent subtilase from the group consisting of BSS168 (BSSAS, BSAPRJ, BSAPRN, BMSAMP), BASBPN, BSSDY, BLSCAR (BLKERA, BLSCA1, BLSCA2, BLSCA3), BSSPRC, and BSSPRD, or functional variants thereof having retained the characteristic of sub-group I-S1.
  • subtilase In relation to variants from subgroup I-S2 it is preferred to select a parent subtilase from the group consisting of BSAPRQ, BLS147 (BSAPRM, BAH101), BLSAVI (BSKSMK, BAALKP, BLSUBL), BYSYAB, BAPB92, TVTHER, and BSAPRS, or functional variants thereof having retained the characteristic of sub-group I-S2.
  • the parent subtilase is BLSAVI (Savinase®, NOVOZYMES A/S), and a preferred subtilase variant of the invention is accordingly a variant of Savinase®.
  • the present invention also encompasses any of the above mentioned subtilase variants in combination with any other modification to the amino acid sequence thereof. Especially combinations with other modifications known in the art to provide improved properties to the enzyme are envisaged.
  • the art describes a number of subtilase variants with different improved properties and a number of those are mentioned in the “Background of the invention” section herein (vide supra). Those references are disclosed here as references to identify a subtilase variant, which advantageously can be combined with a subtilase variant described herein.
  • Such combinations comprise the positions: 222 (improves oxidation stability), 218 (improves thermal stability), substitutions in the Ca 2+ -binding sites stabilizing the enzyme, e.g. position 76, and many other apparent from the prior art.
  • subtilase variant described herein may advantageously be combined with one or more modification(s) in any of the positions:
  • variants comprising any of the modifications S101G+V104N, S87N+S101G+V104N, K27R+V104Y+N123S+T274A, N76D+S103A+V104I or N76D+V104A, or other combinations of the modifications K27R, N76D, S101G, S103A, V104N, V104Y, V104I, V104A, N123S, G159D, A232V, Q236H, Q245R, N248D, N252K, T274A in combination with any one or more of the modification(s) mentioned above exhibit improved properties.
  • a particular interesting variant is a variant, which, in addition to modifications according to the invention, contains the following substitutions:
  • subtilase variants of the main aspect(s) of the invention are preferably combined with one or more modifications(s) in any of the positions 129, 131 and 194, preferably as 129K, 131H and 194P modifications, and most preferably as P129K, P131H and A194P modifications. Any of those modification(s) are expected to provide a higher expression level of the subtilase variant in the production thereof.
  • BPN′ (BASBPN):
  • the wash performance of a selected variant of the invention may be tested in the “Model Detergent Wash Performance Test” disclosed in Example 3 herein.
  • the “Model Detergent Wash Performance Test” may be employed to assess the ability of a variant, when incorporated in a standard detergent composition, to remove proteinaceous stains from a standard textile as compared to a reference system, namely the parent subtilase (incorporated in the same model detergent system and tested under identical conditions). Using this test, the wash performance of a selected variant can be initially investigated, the rationale being that if a selected variant does not show a significant improvement in the test compared to the parent subtilase, it is normally not necessary to carry out further test experiments.
  • variants which are particular interesting for the purposes described herein are such variants which, when tested in a model detergent composition comprising 6.2% LAS (Nansa 80S) 2% Sodium salt of C 16 -C 18 fatty acid 4% Non-ionic surfactant (Plurafax LF404) 22% Zeolite P 10.5% Na 2 CO 3 4% Na 2 Si 2 O 5 2% Carboxymethylcellulose (CMC) 6.8% Acrylate liquid CP5 40% 20% Sodium perborate (empirical formula NaBO 2 .H 2 O 2 ) 0.2% EDTA 21% Na 2 SO 4 Water (balance)
  • the improvement in the wash performance may be quantified by employing the so-called “Performance Factor” defined in Example 3, herein.
  • the variant of the invention when tested in the “Wash Performance Test” has a Performance Factor of at least 1, such as at least 1.5, e.g. at least 2, preferably at least 2.5, such as at least 3, e.g. at least 3.5, in particular at least 4, such as at least 4.5, e.g. at least 5.
  • the variant of the invention fulfils the above criteria on at least the stated lowest level, more preferably at the stated intermediate level and most preferably on the stated highest level.
  • subtilase genes Many methods for cloning a subtilase and for introducing substitutions, deletions or insertions into genes (e.g. subtilase genes) are well known in the art.
  • subtilase variant of the invention In general standard procedures for cloning of genes and introducing mutations (random and/or site directed) into said genes may be used in order to obtain a subtilase variant of the invention.
  • suitable techniques reference is made to Examples herein (vide infra) and (Sambrook et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, N.Y.; Ausubel, F. M. et al. (eds.) “Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.) “Molecular Biological Methods for Bacillus”. John Wiley and Sons, 1990), and WO 96/34946.
  • a subtilase variant may be constructed by standard techniques for artificial creation of diversity, such as by DNA shuffling of different subtilase genes (WO 95/22625; Stemmer WPC, Nature 370:389-91 (1994)). DNA shuffling of e.g. the gene encoding Savinase® with one or more partial subtilase sequences identified in nature, will after subsequent screening for improved wash performance variants, provide subtilase variants suitable for the purposes described herein.
  • a recombinant expression vector comprising a DNA construct encoding the enzyme of the invention may be any vector that may conveniently be subjected to recombinant DNA procedures.
  • the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e. a vector that exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid.
  • the vector may be one that on introduction into a host cell is integrated into the host cell genome in part or in its entirety and replicated together with the chromosome(s) into which it has been integrated.
  • the vector is preferably an expression vector in which the DNA sequence encoding the enzyme of the invention is operably linked to additional segments required for transcription of the DNA.
  • the expression vector is derived from plasmid or viral DNA, or may contain elements of both.
  • operably linked indicates that the segments are arranged so that they function in concert for their intended purposes, e.g. transcription initiates in a promoter and proceeds through the DNA sequence coding for the enzyme.
  • the promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • suitable promoters for use in bacterial host cells include the promoter of the Bacillus stearothermophilus maltogenic amylase gene, the Bacillus licheniformis alpha-amylase gene, the Bacillus amyloliquefaciens alpha-amylase gene, the Bacillus subtilis alkaline protease gene, or the Bacillus pumilus xylosidase gene, or the phage Lambda PR or PL promoters or the E. coli lac, trp or tac promoters.
  • DNA sequence encoding the enzyme of the invention may also, if necessary, be operably connected to a suitable terminator.
  • the recombinant vector of the invention may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
  • the vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, or a gene encoding resistance to e.g. antibiotics like kanamycin, chloramphenicol, erythromycin, tetracycline, spectinomycine, or the like, or resistance to heavy metals or herbicides.
  • a selectable marker e.g. a gene the product of which complements a defect in the host cell, or a gene encoding resistance to e.g. antibiotics like kanamycin, chloramphenicol, erythromycin, tetracycline, spectinomycine, or the like, or resistance to heavy metals or herbicides.
  • a secretory signal sequence (also known as a leader sequence, prepro sequence or pre sequence) may be provided in the recombinant vector.
  • the secretory signal sequence is joined to the DNA sequence encoding the enzyme in the correct reading frame.
  • Secretory signal sequences are commonly positioned 5′ to the DNA sequence encoding the enzyme.
  • the secretory signal sequence may be that normally associated with the enzyme or may be from a gene encoding another secreted protein.
  • the DNA sequence encoding the present enzyme introduced into the host cell may be either homologous or heterologous to the host in question. If homologous to the host cell, i.e. produced by the host cell in nature, it will typically be operably connected to another promoter sequence or, if applicable, another secretory signal sequence and/or terminator sequence than in its natural environment.
  • the term “homologous” is intended to include a DNA sequence encoding an enzyme native to the host organism in question.
  • heterologous is intended to include a DNA sequence not expressed by the host cell in nature. Thus, the DNA sequence may be from another organism, or it may be a synthetic sequence.
  • the host cell into which the DNA construct or the recombinant vector of the invention is introduced may be any cell that is capable of producing the present enzyme and includes bacteria, yeast, fungi and higher eukaryotic cells including plants.
  • Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus, such as strains of B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus, B. megaterium or B. thuringiensis , or strains of Streptomyces, such as S. lividans or S. murinus , or gram-negative bacteria such as Escherichia coli.
  • Bacillus such as strains of B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus, B. megaterium or
  • the transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells in a manner known per se (cf. Sambrook et al., supra).
  • the enzyme When expressing the enzyme in bacteria such as E. coli, the enzyme may be retained in the cytoplasm, typically as insoluble granules (known as inclusion bodies), or may be directed to the periplasmic space by a bacterial secretion sequence. In the former case, the cells are lysed and the granules are recovered and denatured after which the enzyme is refolded by diluting the denaturing agent. In the latter case, the enzyme may be recovered from the periplasmic space by disrupting the cells, e.g. by sonication or osmotic shock, to release the contents of the periplasmic space and recovering the enzyme.
  • the enzyme When expressing the enzyme in gram-positive bacteria such as Bacillus or Streptomyces strains, the enzyme may be retained in the cytoplasm, or may be directed to the extracellular medium by a bacterial secretion sequence. In the latter case, the enzyme may be recovered from the medium as described below.
  • the present invention provides a method of producing an isolated enzyme according to the invention, wherein a suitable host cell, which has been transformed with a DNA sequence encoding the enzyme, is cultured under conditions permitting the production of the enzyme, and the resulting enzyme is recovered from the culture.
  • homologous impurities means any impurities (e.g. other polypeptides than the enzyme of the invention), which originate from the homologous cell where the enzyme of the invention is originally obtained from.
  • the medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question.
  • the expressed subtilase may conveniently be secreted into the culture medium and may be recovered therefrom by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • cleaning and detergent compositions are well described in the art and reference is made to WO 96/34946; WO 97/07202; WO 95/30011 for further description of suitable cleaning and detergent compositions.
  • the subtilase variant may be added to and thus become a component of a detergent composition.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising a subtilase enzyme of the invention.
  • the detergent additive as well as the detergent composition may comprise one or more other enzymes such as another protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • another protease such as another protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include AlcalaseTM, SavinaseTM, PrimaseTM, DuralaseTM, EsperaseTM, and KannaseTM (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, and FN3TM (Genencor International Inc.).
  • Lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa ( T. lanuginosus ) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P.
  • lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Preferred commercially available lipase enzymes include LipolaseTM and Lipolase UltraTM (Novozymes A/S).
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B. licheniformis , described in more detail in GB 1,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
  • amylases are DuramylTM, TermamylTM, FungamylTM and BANTM (Novozymes A/S), RapidaseTM and PurastarTM (from Genencor International Inc.).
  • Cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in U.S. Pat. No. 4,435,307, U.S. Pat. No. 5,648,263, U.S. Pat. No. 5,691,178, U.S. Pat. No. 5,776,757 and WO 89/09259.
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, U.S. Pat. No. 5,457,046, U.S. Pat. No. 5,686,593, U.S. Pat. No. 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
  • cellulases include CelluzymeTM, and CarezymeTM (Novozymes A/S), ClazinaseTM, and Puradax HATM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus , and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
  • the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a detergent additive of the invention i.e. a separate additive or a combined additive, can be formulated e.g. as a granulate, a liquid, a slurry, etc.
  • Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
  • Non-dusting granulates may be produced, e.g., as disclosed in U.S. Pat. Nos. 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art.
  • waxy coating materials are poly(ethylene oxide) products (polyethylene glycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • the detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
  • a liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or non-aqueous.
  • the detergent composition typically comprises one or more surfactants., which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1% to 60% by weight.
  • the detergent will usually contain from about 1% to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, al
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • glucamides N-acyl N-alkyl derivatives of glucosamine
  • the detergent may contain 0-65% of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
  • a bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • a polyol such as propylene glycol or glycerol
  • a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • any enzyme in particular the enzyme of the invention, may be added in an amount corresponding to 0.01-100 mg of enzyme protein per liter of wash liquor, preferably 0.05-5 mg of enzyme protein per liter of wash liquor, in particular 0.1-1 mg of enzyme protein per liter of wash liquor.
  • the enzyme of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202 that is hereby incorporated as reference.
  • the abbreviated component identifications have the following meanings: LAS: Sodium linear C 12 alkyl benzene sulfonate TAS: Sodium tallow alkyl sulfate XYAS: Sodium C 1X -C 1Y alkyl sulfate SS: Secondary soap surfactant of formula 2-butyl octanoic acid 25EY: A C 12 -C 15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide 45EY: A C 14 -C 15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide XYEZS: C 1X -C 1Y sodium alkyl sulfate condensed with an average of Z moles of ethylene oxide per mole
  • Nonionic C 13 -C 15 mixed ethoxylated/propoxylated fatty alcohol with an average degree of ethoxylation of 3.8 and an average degree of propoxylation of 4.5
  • a granular fabric cleaning composition in accordance with the invention may be prepared as follows: Sodium linear C 12 alkyl 6.5 Benzene sulfonate Sodium sulfate 15.0 Zeolite A 26.0 Sodium nitrilotriacetate 5.0 Enzyme 0.1 PVP 0.5 TAED 3.0 Boric acid 4.0 Perborate 18.0 Phenol sulfonate 0.1 Minors up to 100%
  • a compact granular fabric cleaning composition in accord with the invention may be prepared as follows: 45AS 8.0 25E3S 2.0 25E5 3.0 25E3 3.0 TFAA 2.5 Zeolite A 17.0 NaSKS-6 12.0 Citric acid 3.0 Carbonate 7.0 MA/AA 5.0 CMC 0.4 Enzyme 0.1 TAED 6.0 Percarbonate 22.0 EDDS 0.3 Granular suds suppressor 3.5 Water/minors Up to 100%
  • Granular fabric cleaning compositions in accordance with the invention that are especially useful in the laundering of coloured fabrics are prepared as follows: LAS 10.7 — TAS 2.4 — TFAA — 4.0 45AS 3.1 10.0 45E7 4.0 — 25E3S — 3.0 68E11 1.8 — 25E5 — 8.0 Citrate 15.0 7.0 Carbonate — 10.0 Citric acid 2.5 3.0 Zeolite A 32.1 25.0 Na-SKS-6 — 9.0 MA/AA 5.0 5.0 DETPMP 0.2 0.8 Enzyme 0.10 0.05 Silicate 2.5 — Sulfate 5.2 3.0 PVP 0.5 — Poly (4-vinylpyridine)-N- — 0.2 Oxide/copolymer of vinyl- imidazole and vinyl-pyrrolidone Perborate 1.0 — Phenol sulfonate 0.2 — Water/Minors Up to 100%
  • Granular fabric cleaning compositions in accordance with the invention which provide “Softening through the wash” capability may be prepared as follows: 45AS — 10.0 LAS 7.6 — 68AS 1.3 — 45E7 4.0 — 25E3 — 5.0 Coco-alkyl-dimethyl hydroxy- 1.4 1.0 Ethyl ammonium chloride Citrate 5.0 3.0 Na-SKS-6 — 11.0 Zeolite A 15.0 15.0 MA/AA 4.0 4.0 DETPMP 0.4 0.4 Perborate 15.0 — Percarbonate — 15.0 TAED 5.0 5.0 Smectite clay 10.0 10.0 HMWPEO — 0.1 Enzyme 0.10 0.05 Silicate 3.0 5.0 Carbonate 10.0 10.0 Granular suds suppressor 1.0 4.0 CMC 0.2 0.1 Water/Minors Up to 100%
  • Heavy-duty liquid fabric cleaning compositions in accordance with the invention may be prepared as follows: LAS acid form — 25.0 Citric acid 5.0 2.0 25AS acid form 8.0 — 25AE2S acid form 3.0 — 25AE7 8.0 — CFAA 5 — DETPMP 1.0 1.0 Fatty acid 8 — Oleic acid — 1.0 Ethanol 4.0 6.0 Propanediol 2.0 6.0 Enzyme 0.10 0.05 Coco-alkyl dimethyl — 3.0 Hydroxy ethyl ammonium Chloride Smectite clay — 5.0 PVP 2.0 — Water/Minors Up to 100%
  • Powder Automatic Dish Wash Composition I
  • Nonionic surfactant 0.4-2.5%
  • Sodium metasilicate 0-20%
  • Sodium disilicate 3-20%
  • Sodium triphosphate 20-40%
  • Sodium carbonate 0-20%
  • Sodium perborate 2-9%
  • Tetra acetyl ethylene diamine (TAED) 1-4%
  • Sodium sulfate 5-33%
  • Nonionic surfactant 1-2% (e.g. alcohol ethoxylate) Sodium disilicate 2-30% Sodium carbonate 10-50% Sodium phosphonate 0-5% Trisodium citrate dihydrate 9-30% Nitrilotrisodium acetate (NTA) 0-20% Sodium perborate monohydrate 5-10% Tetra-acetyl ethylene diamine (TAED) 1-2% Polyacrylate polymer 6-25% (e.g. maleic acid/acrylic acid co- polymer) Enzymes 0.0001-0.1% Perfume 0.1-0.5% Water 5-10
  • Powder Automatic Dish Wash Composition III Nonionic surfactant 0.5-2.0% Sodium disilicate 25-40% Sodium citrate 30-55% Sodium carbonate 0-29% Sodium bicarbonate 0-20% Sodium perborate monohydrate 0-15% Tetra acetyl ethylene diamine (TAED) 0-6% Maleic acid/acrylic 0-5% acid copolymer Clay 1-3% Polyamino acids 0-20% Sodium polyacrylate 0-8% Enzymes 0.0001-0.1%
  • Nonionic surfactant 1-2% Zeolite MAP 15-42% Sodium disilicate 30-34% Sodium citrate 0-12% Sodium carbonate 0-20% Sodium perborate monohydrate 7-15% Tetra-acetyl ethylene 0-3% diamine (TAED) Polymer 0-4% Maleic acid/acrylic acid copolymer 0-5% Organic phosphonate 0-4% Clay 1-2% Enzymes 0.0001-0.1% Sodium sulfate Balance
  • Powder Automatic Dish Wash Composition V Nonionic surfactant 1-7% Sodium disilicate 18-30% Trisodium citrate 10-24% Sodium carbonate 12-20% Monopersulfate (2 KHSO 5 .KHSO 4 .K 2 SO 4 ) 15-21% Bleach stabilizer 0.1-2% Maleic acid/acrylic acid copolymer 0-6% Diethylene triamine pentaacetate, 0-2.5% pentasodium salt Enzymes 0.0001-0.1% Sodium sulfate, water Balance
  • Nonionic surfactant 0-1.5% Octadecyl dimethylamine N-oxide dihydrate 0-5% 80:20 wt. C18/C16 blend of octadecyl 0-4% dimethylamine N-oxide dihydrate and hexadecyldimethyl amine N-oxide dihydrate 70:30 wt.
  • Non-Aqueous Liquid Automatic Dishwashing Composition VII Liquid nonionic surfactant (e.g. 2.0-10.0% alcohol ethoxylates) Alkali metal silicate 3.0-15.0% Alkali metal phosphate 20.0-40.0% Liquid carrier selected from higher 25.0-45.0% glycols, polyglycols, polyoxides, glycol ethers Stabilizer (e.g. a partial ester of 0.5-7.0% phosphoric acid and a C 16 -C 18 alkanol) Foam suppressor (e.g. silicone) 0-1.5% Enzymes 0.0001-0.1%
  • Non-Aqueous Liquid Dishwashing Composition VIII Liquid nonionic surfactant (e.g. alcohol 2.0-10.0% ethoxylates) Sodium silicate 3.0-15.0% Alkali metal carbonate 7.0-20.0% Sodium citrate 0.0-1.5% Stabilizing system (e.g. mixtures of 0.5-7.0% finely divided silicone and low molecular weight dialkyl polyglycol ethers) Low molecule weight polyacrylate 5.0-15.0% polymer Clay gel thickener (e.g. bentonite) 0.0-10.0% Hydroxypropyl cellulose polymer 0.0-0.6% Enzymes 0.0001-0.1% Liquid carrier selected from higher Balance glycols, polyglycols, polyoxides and glycol ethers
  • Liquid Automatic Dishwashing Composition X Alcohol ethoxylate 0-20% Fatty acid ester sulfonate 0-30% Sodium dodecyl sulfate 0-20% Alkyl polyglycoside 0-21% Oleic acid 0-10% Sodium disilicate monohydrate 18-33% Sodium citrate dihydrate 18-33% Sodium stearate 0-2.5% Sodium perborate monohydrate 0-13% Tetra acetyl ethylene diamine (TAED) 0-8% Maleic acid/acrylic acid copolymer 4-8% Enzymes 0.0001-0.1%
  • Liquid Automatic Dishwashing Composition Containing Protected Bleach Particles XI Sodium silicate 5-10% Tetra potassium pyrophosphate 15-25% Sodium triphosphate 0-2% Potassium carbonate 4-8% Protected bleach particles, e.g. 5-10% chlorine Polymeric thickener 0.7-1.5% Potassium hydroxide 0-2% Enzymes 0.0001-0.1% Water Balance
  • XIII Automatic dishwashing compositions as described in I-VI, which additionally contain a manganese catalyst.
  • the manganese catalyst may, e.g., be one of the compounds described in “Efficient manganese catalysts for low-temperature bleaching”, Nature, (1994), 369, 637-639.
  • Textiles Standard textile pieces are obtained from WFK Testgewebe GmbH, Christenfeld 10, D-41379 Brüggen-Bracht, Germany.
  • B. lentus 309 and 147 are specific strains of Bacillus lentus, deposited with the NCIB and accorded the accession numbers NCIB 10309 and 10147, and described in U.S. Pat. No. 3,723,250 incorporated by reference herein.
  • E. coli MC 1000 (M. J. Casadaban and S. N. Cohen (1980); J. Mol. Biol. 138 179-207), was made r ⁇ ,m + by conventional methods and is also described in U.S. patent application Ser. No. 039,298.
  • pJS3 E. coli - B. subtilis shuttle vector containing a synthetic gene encoding for subtilase 309 (Described by Jacob Schi ⁇ dt et al. in Protein and Peptide letters 3:39-44 (1996)).
  • pSX222 B. subtilis expression vector (described in WO 96/34946).
  • Enzymes for DNA manipulations are used according to the specifications of the suppliers.
  • proteolytic activity is expressed in Kilo NOVO Protease Units (KNPU).
  • KNPU Kilo NOVO Protease Units
  • the activity is determined relatively to an enzyme standard (SAVINASE®), and the determination is based on the digestion of a dimethyl casein (DMC) solution by the proteolytic enzyme at standard conditions, i.e. 50° C., pH 8.3, 9 min. reaction time, 3 min. measuring time.
  • DMC dimethyl casein
  • a folder AF 220/1 is available upon request to Novozymes A/S, Denmark, which folder is hereby included by reference.
  • a GU is a Glycine Unit, defined as the proteolytic enzyme activity that, under standard conditions, during a 15 minutes' incubation at 40° C., with N-acetyl casein as substrate, produces an amount of NH 2 -group equivalent to 1 mmole of glycine.
  • Enzyme activity can also be measured using the PNA assay, according to reaction with the soluble substrate succinyl-alanine-alanine-proline-phenyl-alanine-para-nitro-phenol, which is described in the Journal of American Oil Chemists Society, Rothgeb, T. M., Goodlander, B. D., Garrison, P. H., and Smith, L. A., (1988).
  • Fermentations for the production of subtilase enzymes are performed at 30° C. on a rotary shaking table (300 r.p.m.) in 500 ml baffled Erlenmeyer flasks containing 100 ml BPX medium for 5 days.
  • Media BPX Medium Composition (per liter) Potato starch 100 g Ground barley 50 g Soybean flour 20 g Na 2 HPO 4 ⁇ 12 H 2 O 9 g Pluronic 0.1 g Sodium caseinate 10 g
  • the starch in the medium is liquefied with ⁇ -amylase and the medium is sterilized by heating at 120° C. for 45 minutes. After sterilization the pH of the medium is adjusted to 9 by addition of NaHCO 3 to 0.1 M.
  • Subtilase 309 (Savinase®) site-directed variants of the invention comprising specific insertions/deletions/substitutions are made by traditional cloning of DNA fragments (Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989) produced by PCR with oligos containing the desired mutations (see below).
  • the template plasmid DNA may be pJS3 (see below), or an analogue of this containing a variant of Subtilase 309.
  • Mutations are introduced by oligo directed mutagenesis to the construction of variants.
  • Subtilase 309 variants are transformed into E. coli.
  • DNA purified from an over night culture of these transformants is transformed into B. subtilis by restriction endonuclease digestion, purification of DNA fragments, ligation, transformation of B. subtilis . Transformation of B. subtilis is performed as described by Dubnau et al., 1971, J. Mol. Biol. 56, pp. 209-221.
  • Mutagenic primers are synthesized corresponding to the DNA sequence flanking the sites of mutation, separated by the DNA base pairs defining the insertions/deletions/substitutions.
  • the resulting mutagenic primers are used in a PCR reaction with the modified plasmid pJS3 (see above).
  • the resulting PCR fragment is purified and extended in a second PCR-reaction, the resulting PCR product is purified and extended in a third PCR-reaction before being digested by endonucleases and cloned into the E. coli - B. subtilis shuttle vector (see below).
  • the PCR reactions are performed under normal conditions.
  • the plasmid DNA is transformed into E. coli by well-known techniques and one E. coli colony is sequenced to confirm the mutation designed.
  • a B. subtilis pJS3 expression plasmid comprising a variant of the invention is transformed into a competent B. subtilis strain and fermented as described above.
  • This procedure relates to purification of a 2 liter scale fermentation for the production of the subtilases of the invention in a Bacillus host cell.
  • the filtrates are concentrated to approximately 400 ml using an Amicon CH2A UF unit equipped with an Amicon S1Y10 UF cartridge.
  • the UF concentrate is centrifuged and filtered prior to absorption at room temperature on a Bacitracin affinity column at pH 7.
  • the protease is eluted from the Bacitracin column at room temperature using 25% 2-propanol and 1 M sodium chloride in a buffer solution with 0.01 dimethylglutaric acid, 0.1 M boric acid and 0.002 M calcium chloride adjusted to pH 7.
  • protease is eluted using a linear gradient of 0-0.1 M sodium chloride in 2 litres of the same buffer (0-0.2 M sodium chloride in case of Subtilisin 147).
  • protease containing fractions from the CM Sepharose column are combined and concentrated in an Amicon ultrafiltration cell equipped with a GR81PP membrane (from the Danish Sugar Factories Inc.).
  • BPN′ (BASBPN):
  • composition of the model detergent is as follows: 6.2% LAS (Nansa 80S) 2% Sodium salt of C 16 -C 18 fatty acid 4% Non-ionic surfactant (Plurafax LF404) 22% Zeolite P 10.5% Na 2 CO 3 4% Na 2 Si 2 O 5 2% Carboxymethylcellulose (CMC) 6.8% Acrylate liquid CP5 40% 20% Sodium perborate (empirical formula NaBO 2 .H 2 O 2 ) 0.2% EDTA 21% Na 2 SO 4
  • pH of the detergent solution is adjusted to 10.1 by addition of HCl or NaOH.
  • Measurement of the reflectance (R variant ) on the test material is performed at 460 nm using a Macbeth ColorEye 7000 photometer (Macbeth, Division of Kollmorgen Instruments Corporation, Germany). The measurements are performed in accordance with the manufacturer's protocol.
  • a reference experiment is then performed as described above, wherein the wash performance of the parent enzyme is tested.
  • the subsequent measurement of the reflectance (R parent ) is performed as described right above.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
US10/481,723 2001-07-12 2002-07-11 Subtilase variants Abandoned US20040197894A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US12/035,766 US20080167213A1 (en) 2001-07-12 2008-02-22 Subtilase Variants
US13/038,717 US20110152155A1 (en) 2001-07-12 2011-03-02 Subtilase variants
US13/872,191 US8569035B2 (en) 2001-07-12 2013-04-29 Subtilase variants
US14/035,241 US20140018283A1 (en) 2001-07-12 2013-09-24 Subtilase Variants
US14/502,234 US9528100B2 (en) 2001-07-12 2014-09-30 Subtilase variants
US15/355,435 US10351837B2 (en) 2001-07-12 2016-11-18 Subtilase variants

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200101090A DK200101090A (da) 2001-07-12 2001-07-12 Subtilase variants
DKPA200101090 2001-07-12
PCT/DK2002/000485 WO2003006602A2 (en) 2001-07-12 2002-07-11 Subtilase variants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2002/000485 A-371-Of-International WO2003006602A2 (en) 2001-07-12 2002-07-11 Subtilase variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/035,766 Continuation US20080167213A1 (en) 2001-07-12 2008-02-22 Subtilase Variants

Publications (1)

Publication Number Publication Date
US20040197894A1 true US20040197894A1 (en) 2004-10-07

Family

ID=8160620

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/481,723 Abandoned US20040197894A1 (en) 2001-07-12 2002-07-11 Subtilase variants
US12/035,766 Abandoned US20080167213A1 (en) 2001-07-12 2008-02-22 Subtilase Variants
US13/038,717 Abandoned US20110152155A1 (en) 2001-07-12 2011-03-02 Subtilase variants
US13/872,191 Expired - Fee Related US8569035B2 (en) 2001-07-12 2013-04-29 Subtilase variants
US14/035,241 Abandoned US20140018283A1 (en) 2001-07-12 2013-09-24 Subtilase Variants
US14/502,234 Expired - Fee Related US9528100B2 (en) 2001-07-12 2014-09-30 Subtilase variants
US15/355,435 Expired - Fee Related US10351837B2 (en) 2001-07-12 2016-11-18 Subtilase variants

Family Applications After (6)

Application Number Title Priority Date Filing Date
US12/035,766 Abandoned US20080167213A1 (en) 2001-07-12 2008-02-22 Subtilase Variants
US13/038,717 Abandoned US20110152155A1 (en) 2001-07-12 2011-03-02 Subtilase variants
US13/872,191 Expired - Fee Related US8569035B2 (en) 2001-07-12 2013-04-29 Subtilase variants
US14/035,241 Abandoned US20140018283A1 (en) 2001-07-12 2013-09-24 Subtilase Variants
US14/502,234 Expired - Fee Related US9528100B2 (en) 2001-07-12 2014-09-30 Subtilase variants
US15/355,435 Expired - Fee Related US10351837B2 (en) 2001-07-12 2016-11-18 Subtilase variants

Country Status (11)

Country Link
US (7) US20040197894A1 (de)
EP (1) EP1409659B1 (de)
JP (1) JP4383858B2 (de)
CN (1) CN1537163A (de)
AT (1) ATE409744T1 (de)
AU (1) AU2002316816A1 (de)
DE (1) DE60229136D1 (de)
DK (1) DK200101090A (de)
NZ (2) NZ530237A (de)
WO (1) WO2003006602A2 (de)
ZA (1) ZA200309666B (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050003986A1 (en) * 1988-01-07 2005-01-06 Novozymes A/S Useful mutations of bacterial alkaline protease
WO2006064721A1 (ja) * 2004-12-13 2006-06-22 The New Industry Research Organization 低温活性型サチライシン
US20070015677A1 (en) * 2003-05-07 2007-01-18 Novozymes A/S Variant subtilising enzymes (subtilases)
US20070161531A1 (en) * 2005-07-08 2007-07-12 Novozymes A/S Subtilase variants
US20070270574A1 (en) * 2000-04-03 2007-11-22 Novozymes A/S Subtilisin variants
WO2009021867A3 (de) * 2007-08-10 2009-04-02 Henkel Ag & Co Kgaa Mittel enthaltend proteasen
US9732310B2 (en) 2002-11-06 2017-08-15 Novozymes A/S Subtilase variants
WO2018118917A1 (en) * 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Families Citing this family (315)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682924B1 (en) * 1995-05-05 2004-01-27 Novozymes A/S Protease variants and compositions
US20120165241A1 (en) * 1995-05-05 2012-06-28 Unilever Plc Subtilase Variants
ATE385254T1 (de) * 1997-08-29 2008-02-15 Novozymes As Proteasevarianten und zusammensetzungen
CA2417547A1 (en) 2000-07-28 2003-01-28 Henkel Kommanditgesellschaft Auf Aktien Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme
DK200101090A (da) 2001-07-12 2001-08-16 Novozymes As Subtilase variants
TWI319007B (en) * 2002-11-06 2010-01-01 Novozymes As Subtilase variants
WO2009095425A1 (en) 2008-02-01 2009-08-06 Novozymes A/S Liquid enzyme composition
EP2271660B1 (de) 2008-03-26 2020-05-06 Novozymes A/S Stabilisierte flüssige enzymzusammensetzung
US8753861B2 (en) * 2008-11-11 2014-06-17 Danisco Us Inc. Protease comprising one or more combinable mutations
CN102209778B (zh) * 2008-11-11 2014-10-15 丹尼斯科美国公司 包含丝氨酸蛋白酶变体的组合物和方法
GB0915572D0 (en) * 2009-09-07 2009-10-07 Reckitt Benckiser Nv Detergent composition
MX2012006616A (es) 2009-12-09 2012-06-21 Procter & Gamble Productos para el cuidado de las telas y el hogar.
EP3095861B1 (de) * 2010-05-06 2019-06-26 The Procter and Gamble Company Konsumgüter mit proteasevarianten
EP2689015B1 (de) 2011-03-23 2015-01-07 Novozymes A/S Verfahren zur herstellung sezernierter polypeptide
ES2809509T3 (es) * 2011-05-05 2021-03-04 Procter & Gamble Composiciones y métodos que comprenden variantes de serina proteasa
CN103649289A (zh) 2011-07-01 2014-03-19 诺维信公司 液体洗涤剂组合物
CN107858217B (zh) 2011-07-01 2021-03-23 诺维信公司 稳定化的枯草杆菌蛋白酶组合物
EP2734633B1 (de) 2011-07-22 2019-05-01 Novozymes North America, Inc. Verfahren zur vorbehandlung von cellulosematerial und verbesserung deren hydrolyse
WO2013076269A1 (en) 2011-11-25 2013-05-30 Novozymes A/S Subtilase variants and polynucleotides encoding same
EP2607468A1 (de) 2011-12-20 2013-06-26 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzungen mit Subtilasevarianten
CN104011204A (zh) 2011-12-20 2014-08-27 诺维信公司 枯草杆菌酶变体和编码它们的多核苷酸
BR112014017919A2 (pt) 2012-01-26 2017-06-27 Novozymes As uso de um poliptídeo variante, composição, polinucleotídeo isolado, constructo de ácido nucleico ou vetor de expressão, célula hospedeira de expressão recombinante, métodos de produção do pilipeptídeo, para melhoria do valor nutricional de uma ração animal, e para o tratamento de proteínas, planta, parte de planta ou célula de planta transgênica, aditivo de ração animal, ração animal, e, composição de ração animal ou detergente
EP2628785B1 (de) 2012-02-17 2016-05-18 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzungen mit Subtilasevarianten
JP2015509364A (ja) 2012-02-17 2015-03-30 ノボザイムス アクティーゼルスカブ サブチリシン変異体およびそれをコードするポリヌクレオチド
DK2847308T3 (en) 2012-05-07 2017-10-23 Novozymes As Polypeptides with xanthan-degrading activity and polynucleotides encoding them
WO2013171241A1 (en) 2012-05-16 2013-11-21 Novozymes A/S Compositions comprising lipase and methods of use thereof
AU2013279440B2 (en) 2012-06-20 2016-10-06 Novozymes A/S Use of polypeptides having protease activity in animal feed and detergents
US20160145540A1 (en) 2012-08-22 2016-05-26 Novozymes A/S Detergent Compositions Comprising Metalloproteases
US9315791B2 (en) 2012-08-22 2016-04-19 Novozymes A/S Metalloproteases from alicyclobacillus
EP2888361A1 (de) 2012-08-22 2015-07-01 Novozymes A/S Metalloprotease aus exiguobacterium
EP2925849A2 (de) * 2012-11-30 2015-10-07 Novozymes A/S Polypeptide für reinigungs- oder waschmittelzusammensetzungen
JP6514107B2 (ja) 2012-12-07 2019-05-15 ノボザイムス アクティーゼルスカブ 細菌の付着防止
EP2934177B1 (de) 2012-12-21 2017-10-25 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide zur codierung davon
US9902946B2 (en) 2013-01-03 2018-02-27 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
WO2014152674A1 (en) 2013-03-14 2014-09-25 Novozymes A/S Enzyme and inhibitor containing water-soluble films
WO2014173980A2 (en) 2013-04-23 2014-10-30 Novozymes A/S Liquid automatic dish washing detergent compositions
EP3461881B1 (de) 2013-05-03 2024-10-09 Novozymes A/S Mikroverkapselung von wasch- und reinigungsmittelenzymen
AR096270A1 (es) 2013-05-14 2015-12-16 Novozymes As Composiciones detergentes
US20160083703A1 (en) 2013-05-17 2016-03-24 Novozymes A/S Polypeptides having alpha amylase activity
US10538751B2 (en) 2013-06-06 2020-01-21 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
US10378001B2 (en) 2013-06-27 2019-08-13 Novozymes A/S Subtilase variants and compositions comprising same
EP3013955A1 (de) 2013-06-27 2016-05-04 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
US20160152925A1 (en) 2013-07-04 2016-06-02 Novozymes A/S Polypeptides Having Anti-Redeposition Effect and Polynucleotides Encoding Same
EP3019603A1 (de) 2013-07-09 2016-05-18 Novozymes A/S Polypeptide mit lipaseaktivität und polynukleotide zur codierung davon
EP3339436B1 (de) 2013-07-29 2021-03-31 Henkel AG & Co. KGaA Waschmittelzusammensetzung mit proteasevarianten
WO2015014803A1 (en) 2013-07-29 2015-02-05 Novozymes A/S Protease variants and polynucleotides encoding same
CN117904081A (zh) 2013-07-29 2024-04-19 诺维信公司 蛋白酶变体以及对其进行编码的多核苷酸
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EP3083954B1 (de) 2013-12-20 2018-09-26 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide, die für diese kodieren
US10208297B2 (en) 2014-01-22 2019-02-19 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same for cleaning
EP3114272A1 (de) 2014-03-05 2017-01-11 Novozymes A/S Zusammensetzungen und verfahren zur verbesserung der eigenschaften von cellulosischen textilmaterialien mit xyloglucan-endotransglycosylase
US20160348035A1 (en) 2014-03-05 2016-12-01 Novozymes A/S Compositions and Methods for Improving Properties of Non-Cellulosic Textile Materials with Xyloglucan Endotransglycosylase
US10155935B2 (en) 2014-03-12 2018-12-18 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
US20170015950A1 (en) 2014-04-01 2017-01-19 Novozymes A/S Polypeptides having alpha amylase activity
BR112016023188A2 (pt) 2014-04-11 2018-01-16 Novozymes As uso de um polipeptídeo, composição detergente, métodos de lavagem para a lavagem de um item e de produção do polipeptídeo, polipeptídeo isolado, construção de ácido nucleico ou vetor de expressão, célula hospedeira recombinante, e, formulação de caldo inteiro ou composição de cultura de células
CN106715465B (zh) 2014-04-15 2021-10-08 诺维信公司 具有脂肪酶活性的多肽和编码它们的多核苷酸
WO2015181118A1 (en) 2014-05-27 2015-12-03 Novozymes A/S Methods for producing lipases
EP3760713A3 (de) 2014-05-27 2021-03-31 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
US20170121695A1 (en) 2014-06-12 2017-05-04 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
WO2016001319A1 (en) 2014-07-03 2016-01-07 Novozymes A/S Improved stabilization of non-protease enzyme
EP3739029A1 (de) 2014-07-04 2020-11-18 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
CN106661566A (zh) 2014-07-04 2017-05-10 诺维信公司 枯草杆菌酶变体以及编码它们的多核苷酸
WO2016079110A2 (en) 2014-11-19 2016-05-26 Novozymes A/S Use of enzyme for cleaning
US10287562B2 (en) 2014-11-20 2019-05-14 Novoszymes A/S Alicyclobacillus variants and polynucleotides encoding same
EP4067485A3 (de) 2014-12-05 2023-01-04 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
ES2763235T3 (es) 2014-12-15 2020-05-27 Henkel Ag & Co Kgaa Composición detergente que comprende variantes de subtilasa
WO2016096996A1 (en) 2014-12-16 2016-06-23 Novozymes A/S Polypeptides having n-acetyl glucosamine oxidase activity
EP3234093B1 (de) 2014-12-19 2020-05-27 Novozymes A/S Proteasevarianten und dafür codierende polynukleotide
CN118497177A (zh) 2014-12-19 2024-08-16 诺维信公司 蛋白酶变体以及对其进行编码的多核苷酸
JP6748099B2 (ja) 2015-03-30 2020-08-26 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳ベースタンパク質加水分解物及びそれから作製された組成物
WO2016162556A1 (en) 2015-04-10 2016-10-13 Novozymes A/S Laundry method, use of dnase and detergent composition
EP3280800A1 (de) 2015-04-10 2018-02-14 Novozymes A/S Reinigungsmittelzusammensetzung
WO2016184944A1 (en) 2015-05-19 2016-11-24 Novozymes A/S Odor reduction
EP3303536B1 (de) 2015-06-02 2019-04-17 Unilever PLC Waschmittelzusammensetzung
EP3101108B1 (de) 2015-06-04 2018-01-31 The Procter and Gamble Company Flüssige handspülmittelzusammensetzung
EP3101109B1 (de) 2015-06-04 2018-03-07 The Procter and Gamble Company Flüssige handspülmittelzusammensetzung
EP3101102B2 (de) 2015-06-05 2023-12-13 The Procter & Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
EP3101107B1 (de) 2015-06-05 2019-04-24 The Procter and Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
PL3101100T3 (pl) 2015-06-05 2018-07-31 The Procter And Gamble Company Zagęszczone płynne kompozycje detergentowe do prania
WO2016198262A1 (en) 2015-06-11 2016-12-15 Unilever Plc Laundry detergent composition
CN108012543B (zh) 2015-06-16 2022-01-04 诺维信公司 具有脂肪酶活性的多肽和编码它们的多核苷酸
EP3310688A1 (de) 2015-06-17 2018-04-25 Novozymes A/S Behälter
CN108012544A (zh) * 2015-06-18 2018-05-08 诺维信公司 枯草杆菌酶变体以及编码它们的多核苷酸
EP3313966B1 (de) 2015-06-26 2020-07-29 Unilever PLC Waschmittelzusammensetzung
WO2016135351A1 (en) 2015-06-30 2016-09-01 Novozymes A/S Laundry detergent composition, method for washing and use of composition
CN107922930A (zh) 2015-07-01 2018-04-17 诺维信公司 减少气味的方法
CN107969136B (zh) 2015-07-06 2021-12-21 诺维信公司 脂肪酶变体以及编码它们的多核苷酸
CN108026487B (zh) 2015-09-17 2021-04-30 汉高股份有限及两合公司 包含具有黄原胶降解活性的多肽的洗涤剂组合物
CN108350443B (zh) 2015-09-17 2022-06-28 诺维信公司 具有黄原胶降解活性的多肽以及编码它们的多核苷酸
BR112018006212B1 (pt) 2015-10-01 2022-04-12 Unilever Ip Holdings B.V. Composição de detergente em pó formada por carbonato sem fosfato e método de tratamento doméstico de um tecido
CN116064474A (zh) 2015-10-07 2023-05-05 诺维信公司 多肽
US10479981B2 (en) 2015-10-14 2019-11-19 Novozymes A/S DNase variants
JP2018531783A (ja) 2015-10-14 2018-11-01 ノボザイムス アクティーゼルスカブ 水濾過膜の洗浄
US20180171318A1 (en) 2015-10-14 2018-06-21 Novozymes A/S Polypeptides Having Protease Activity and Polynucleotides Encoding Same
MX388896B (es) 2015-10-28 2025-03-20 Novozymes As Composicion detergente que comprende variantes de amilasa y proteasa.
CN108473974A (zh) 2015-11-24 2018-08-31 诺维信公司 具有蛋白酶活性的多肽以及编码其的多核苷酸
CN108431217B (zh) 2015-12-01 2022-06-21 诺维信公司 用于产生脂肪酶的方法
ES2932192T3 (es) 2015-12-07 2023-01-16 Henkel Ag & Co Kgaa Composiciones para el lavado de vajilla que comprenden polipéptidos que tienen actividad beta-glucanasa y sus usos
ES2964738T3 (es) * 2015-12-23 2024-04-09 Envirozyme Llc Métodos para potenciar el drenaje de residuos con tratamiento enzimático
US11623885B2 (en) 2015-12-23 2023-04-11 Novozymes A/S Methods for enhancing the dewaterability of sludge with enzyme treatment
WO2017117089A1 (en) 2015-12-28 2017-07-06 Novozymes Bioag A/S Heat priming of bacterial spores
MX2018008051A (es) 2016-01-29 2018-08-23 Novozymes As Variantes de beta-glucanasa y polinucleotidos que las codifican.
EP3417040B1 (de) 2016-02-17 2019-09-04 Unilever PLC Bleichungszusammensetzung
CN108884415A (zh) 2016-03-21 2018-11-23 荷兰联合利华有限公司 洗衣洗涤剂组合物
BR112018069220A2 (pt) 2016-03-23 2019-01-22 Novozymes As uso de polipeptídeo que tem atividade de dnase para tratamento de tecidos
DE102016204814A1 (de) 2016-03-23 2017-09-28 Henkel Ag & Co. Kgaa Verbesserte Reinigungsleistung an Protein sensitiven Anschmutzungen
CN109312270B (zh) 2016-04-08 2022-01-28 诺维信公司 洗涤剂组合物及其用途
CN108779416B (zh) 2016-04-08 2021-01-05 荷兰联合利华有限公司 洗衣洗涤剂组合物
EP3693449A1 (de) 2016-04-29 2020-08-12 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2017210188A1 (en) 2016-05-31 2017-12-07 Novozymes A/S Stabilized liquid peroxide compositions
DE102016210628A1 (de) 2016-06-15 2017-12-21 Henkel Ag & Co. Kgaa Bacillus gibsonii Protease und Varianten davon
EP3475404A1 (de) 2016-06-23 2019-05-01 Novozymes A/S Verwendung von enzymen, zusammensetzung und verfahren zum entfernen von schmutz
EP3478827B1 (de) 2016-06-30 2024-06-19 Novozymes A/S Lipase-varianten und zusammensetzungen mit tensid- und lipase-variante
WO2018002261A1 (en) 2016-07-01 2018-01-04 Novozymes A/S Detergent compositions
WO2018007573A1 (en) 2016-07-08 2018-01-11 Novozymes A/S Detergent compositions with galactanase
ES3000090T3 (en) 2016-07-13 2025-02-27 Procter & Gamble Bacillus cibi dnase variants and uses thereof
EP3485008B1 (de) 2016-07-18 2024-01-31 Novozymes A/S Lipasevarianten, polynukleotide zur codierung davon und verwendung davon
KR20190039192A (ko) 2016-08-08 2019-04-10 바스프 에스이 액체 세탁 제형
EP3284805B1 (de) 2016-08-17 2020-02-19 The Procter & Gamble Company Reinigungszusammensetzung
KR102483218B1 (ko) 2016-08-24 2023-01-02 헨켈 아게 운트 코. 카게아아 크산탄 리아제 변이체 i을 포함하는 세제 조성물
US11512300B2 (en) 2016-08-24 2022-11-29 Novozymes A/S Xanthan lyase variants and polynucleotides encoding same
CA3031609A1 (en) 2016-08-24 2018-03-01 Novozymes A/S Gh9 endoglucanase variants and polynucleotides encoding same
US10988747B2 (en) 2016-08-24 2021-04-27 Henkel Ag & Co. Kgaa Detergent composition comprising GH9 endoglucanase variants I
CN109790491B (zh) 2016-09-27 2021-02-23 荷兰联合利华有限公司 家用洗衣方法
US20200140786A1 (en) 2016-09-29 2020-05-07 Novozymes A/S Use of enzyme for washing, method for washing and warewashing composition
CN109996859B (zh) 2016-09-29 2021-11-30 诺维信公司 含孢子的颗粒
EP3532592A1 (de) 2016-10-25 2019-09-04 Novozymes A/S Waschmittelzusammensetzungen
US11753605B2 (en) 2016-11-01 2023-09-12 Novozymes A/S Multi-core granules
KR20190086540A (ko) 2016-12-01 2019-07-22 바스프 에스이 조성물 중 효소의 안정화
US20190292493A1 (en) 2016-12-12 2019-09-26 Novozymes A/S Use of polypeptides
EP3555255B1 (de) 2016-12-15 2020-06-24 Unilever PLC Waschmittelzusammensetzung
WO2018177203A1 (en) 2017-03-31 2018-10-04 Novozymes A/S Polypeptides having dnase activity
US11053483B2 (en) 2017-03-31 2021-07-06 Novozymes A/S Polypeptides having DNase activity
WO2018177938A1 (en) 2017-03-31 2018-10-04 Novozymes A/S Polypeptides having dnase activity
EP3601551A1 (de) 2017-03-31 2020-02-05 Novozymes A/S Polypeptide mit rnase-aktivität
US20200109354A1 (en) 2017-04-04 2020-04-09 Novozymes A/S Polypeptides
WO2018185181A1 (en) 2017-04-04 2018-10-11 Novozymes A/S Glycosyl hydrolases
US20200109352A1 (en) 2017-04-04 2020-04-09 Novozymes A/S Polypeptide compositions and uses thereof
DK3385361T3 (da) 2017-04-05 2019-06-03 Ab Enzymes Gmbh Detergentsammensætninger omfattende bakterielle mannanaser
EP3385362A1 (de) 2017-04-05 2018-10-10 Henkel AG & Co. KGaA Waschmittelzusammensetzungen mit pilzmannanasen
EP3607042A1 (de) 2017-04-06 2020-02-12 Novozymes A/S Reinigungszusammensetzungen und verwendungen davon
US11499121B2 (en) 2017-04-06 2022-11-15 Novozymes A/S Detergent compositions and uses thereof
EP3478811B1 (de) 2017-04-06 2019-10-16 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2018184816A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
US20200190438A1 (en) 2017-04-06 2020-06-18 Novozymes A/S Cleaning compositions and uses thereof
US20200190437A1 (en) 2017-04-06 2020-06-18 Novozymes A/S Cleaning compositions and uses thereof
US11078445B2 (en) 2017-05-05 2021-08-03 Novozymes A/S Compositions comprising lipase and sulfite
WO2018206535A1 (en) 2017-05-08 2018-11-15 Novozymes A/S Carbohydrate-binding domain and polynucleotides encoding the same
EP3401385A1 (de) 2017-05-08 2018-11-14 Henkel AG & Co. KGaA Tensidzusammensetzungen enthaltend polypeptide enthaltend eine carbohydrate binding domain
WO2018224544A1 (en) 2017-06-08 2018-12-13 Novozymes A/S Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions
EP3645692B1 (de) 2017-06-30 2025-12-31 Novozymes A/S Enzymschlammzusammensetzung
CN110869483B (zh) 2017-07-24 2026-03-10 法国特种经营公司 含酶的洗涤剂组合物
US20210130744A1 (en) 2017-08-24 2021-05-06 Henkel Ag & Co. Kgaa Detergent composition comprising xanthan lyase variants ii
US11624059B2 (en) 2017-08-24 2023-04-11 Henkel Ag & Co. Kgaa Detergent compositions comprising GH9 endoglucanase variants II
US11525128B2 (en) 2017-08-24 2022-12-13 Novozymes A/S GH9 endoglucanase variants and polynucleotides encoding same
WO2019038057A1 (en) 2017-08-24 2019-02-28 Novozymes A/S VARIANTS OF XANTHANE LYASE AND POLYNUCLEOTIDES ENCODING THE SAME
CN111247235A (zh) 2017-09-20 2020-06-05 诺维信公司 酶改善吸水性和/或白度的用途
US11414814B2 (en) 2017-09-22 2022-08-16 Novozymes A/S Polypeptides
JP7317811B2 (ja) 2017-09-27 2023-07-31 ノボザイムス アクティーゼルスカブ リパーゼ変異体及びかかるリパーゼ変異体を含むマイクロカプセル組成物
EP3461892A3 (de) 2017-09-27 2019-06-12 The Procter & Gamble Company Waschmittelzusammensetzungen mit lipasen
WO2019068715A1 (en) 2017-10-02 2019-04-11 Novozymes A/S POLYPEPTIDES HAVING MANNANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING THESE POLYPEPTIDES
US11746310B2 (en) 2017-10-02 2023-09-05 Novozymes A/S Polypeptides having mannanase activity and polynucleotides encoding same
US20200318037A1 (en) 2017-10-16 2020-10-08 Novozymes A/S Low dusting granules
CN111448302A (zh) 2017-10-16 2020-07-24 诺维信公司 低粉化颗粒
WO2019076800A1 (en) 2017-10-16 2019-04-25 Novozymes A/S CLEANING COMPOSITIONS AND USES THEREOF
US11866748B2 (en) 2017-10-24 2024-01-09 Novozymes A/S Compositions comprising polypeptides having mannanase activity
PL3476935T3 (pl) 2017-10-27 2022-03-28 The Procter & Gamble Company Kompozycje detergentowe zawierające odmiany polipeptydowe
MX2020004145A (es) 2017-10-27 2020-08-03 Novozymes As Variantes de desoxirribonucleasa (dnasa).
EP3704240A1 (de) 2017-11-01 2020-09-09 Novozymes A/S Polypeptide und zusammensetzungen mit solchen polypeptiden
DE102017125560A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine iii enthalten
CN111527190A (zh) 2017-11-01 2020-08-11 诺维信公司 多肽以及包含此类多肽的组合物
DE102017125559A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine ii enthalten
US11505767B2 (en) 2017-11-01 2022-11-22 Novozymes A/S Methods for cleansing medical devices
DE102017125558A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine i enthalten
KR20200088433A (ko) 2017-11-29 2020-07-22 바스프 에스이 보관 안정한 효소 제제, 이것의 제조 및 용도
CN111670248A (zh) 2017-12-04 2020-09-15 诺维信公司 脂肪酶变体以及编码其的多核苷酸
WO2019154952A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipase variants and compositions thereof
EP3749761A1 (de) 2018-02-08 2020-12-16 Novozymes A/S Lipasen, lipasevarianten und zusammensetzungen davon
EP3755793A1 (de) 2018-02-23 2020-12-30 Henkel AG & Co. KGaA Waschmittelzusammensetzung mit xanthan lyase und endoglucanasevarianten
US20210002588A1 (en) 2018-03-13 2021-01-07 Novozymes A/S Microencapsulation Using Amino Sugar Oligomers
CN112262207B (zh) 2018-04-17 2024-01-23 诺维信公司 洗涤剂组合物中包含碳水化合物结合活性的多肽及其在减少纺织品或织物中的褶皱的用途
EP3781679A1 (de) 2018-04-19 2021-02-24 Novozymes A/S Stabilisierte cellulase-varianten
EP3781680A1 (de) 2018-04-19 2021-02-24 Novozymes A/S Stabilisierte cellulase-varianten
US11732250B2 (en) 2018-04-26 2023-08-22 Basf Se Lipase enzymes
US20210115422A1 (en) 2018-05-03 2021-04-22 Basf Se Amylase enzymes
WO2019238761A1 (en) 2018-06-15 2019-12-19 Basf Se Water soluble multilayer films containing wash active chemicals and enzymes
EP3814472A1 (de) 2018-06-28 2021-05-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2020002608A1 (en) 2018-06-29 2020-01-02 Novozymes A/S Detergent compositions and uses thereof
EP3818139A1 (de) 2018-07-02 2021-05-12 Novozymes A/S Reinigungszusammensetzungen und verwendungen davon
WO2020007875A1 (en) 2018-07-03 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
WO2020008024A1 (en) 2018-07-06 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
WO2020030623A1 (en) 2018-08-10 2020-02-13 Basf Se Packaging unit comprising a detergent composition containing an enzyme and at least one chelating agent
US20210340466A1 (en) 2018-10-01 2021-11-04 Novozymes A/S Detergent compositions and uses thereof
WO2020070011A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
WO2020070014A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition comprising anionic surfactant and a polypeptide having rnase activity
WO2020070209A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
WO2020070009A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Endonuclease 1 ribonucleases for cleaning
WO2020070249A1 (en) 2018-10-03 2020-04-09 Novozymes A/S Cleaning compositions
EP3861008A1 (de) 2018-10-03 2021-08-11 Novozymes A/S Polypeptide mit alpha-mannan-abbauender aktivität und polynukleotide zur codierung davon
CN112805376A (zh) 2018-10-05 2021-05-14 巴斯夫欧洲公司 在液体中稳定水解酶的化合物
EP3677676A1 (de) 2019-01-03 2020-07-08 Basf Se Verbindungen zur stabilisierung von amylasen in flüssigkeiten
CN112805377A (zh) 2018-10-05 2021-05-14 巴斯夫欧洲公司 在液体中稳定淀粉酶的化合物
MX2021003930A (es) 2018-10-05 2021-06-04 Basf Se Compuestos estabilizadores de hidrolasas en liquidos.
CN112996894A (zh) 2018-10-11 2021-06-18 诺维信公司 清洁组合物及其用途
ES2981999T3 (es) 2018-10-31 2024-10-14 Henkel Ag & Co Kgaa Composiciones limpiadoras que contienen dispersinas V
EP3647397A1 (de) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Reinigungsmittel mit dispersins iv
WO2020104231A1 (en) 2018-11-19 2020-05-28 Basf Se Powders and granules containing a chelating agent and an enzyme
CN113302270A (zh) 2018-12-03 2021-08-24 诺维信公司 低pH粉末洗涤剂组合物
CN113366103A (zh) 2018-12-21 2021-09-07 诺维信公司 具有肽聚糖降解活性的多肽以及编码其的多核苷酸
CN113330101A (zh) 2018-12-21 2021-08-31 诺维信公司 包含金属蛋白酶的洗涤剂袋
MX2021010109A (es) 2019-02-20 2021-09-21 Basf Se Proceso de fermentacion industrial para bacillus mediante el uso de un medio definido y una alimentacion de oligoelementos.
US20220186177A1 (en) 2019-02-20 2022-06-16 Basf Se Industrial fermentation process for bacillus using defined medium and magnesium feed
AU2020242303B2 (en) 2019-03-21 2026-01-08 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
US11299439B2 (en) * 2019-04-01 2022-04-12 Valent Biosciences Llc Mycorrhizae and/or Bacillus amyloliquefaciens liquid fertilizer compatible formulations
MX2021011981A (es) 2019-04-03 2021-11-03 Novozymes As Polipeptidos que tienen actividad de beta-glucanasa, polinucleotidos que los codifican y usos de los mismos en composiciones de limpieza y de detergente.
EP3953462A1 (de) 2019-04-10 2022-02-16 Novozymes A/S Polypeptidvarianten
CN113795576A (zh) 2019-04-12 2021-12-14 诺维信公司 稳定化的糖苷水解酶变体
WO2020229480A1 (en) 2019-05-14 2020-11-19 Basf Se Compounds stabilizing hydrolases in liquids
MX2021015364A (es) 2019-06-13 2022-01-24 Basf Se Metodo de recuperacion de una proteina de un caldo de fermentacion mediante el uso de un cation divalente.
EP3994148A1 (de) 2019-07-01 2022-05-11 Basf Se Peptideacetale zur stabilisierung von enzymen
US20220340865A1 (en) 2019-07-02 2022-10-27 Basf Se Method for preparing a fermentation medium
EP3994255A1 (de) 2019-07-02 2022-05-11 Novozymes A/S Lipasevarianten und zusammensetzungen davon
PL3959326T3 (pl) 2019-07-05 2023-10-09 Basf Se Przemysłowy sposób fermentacji dla komórek bakteryjnych z wykorzystaniem kultury wstępnej okresowej z zasilaniem
CN114364778B (zh) 2019-07-12 2024-08-13 诺维信公司 用于洗涤剂的酶性乳剂
WO2021030400A1 (en) 2019-08-13 2021-02-18 Novozymes Bioag A/S Pesticidal combinations of yersinia and proteases
US20220325204A1 (en) 2019-08-27 2022-10-13 Novozymes A/S Detergent composition
EP4022020A1 (de) 2019-08-27 2022-07-06 Novozymes A/S Lipase enthaltende zusammensetzung
US20220315866A1 (en) 2019-09-19 2022-10-06 Novozymes A/S Detergent Composition
US20220340843A1 (en) 2019-10-03 2022-10-27 Novozymes A/S Polypeptides comprising at least two carbohydrate binding domains
CN114585718A (zh) 2019-10-18 2022-06-03 巴斯夫欧洲公司 储存稳定的包含水解酶的液体
CN113891931A (zh) 2019-11-29 2022-01-04 巴斯夫欧洲公司 组合物和可以用于该类组合物的聚合物
WO2021115912A1 (en) 2019-12-09 2021-06-17 Basf Se Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes
WO2021121394A1 (en) 2019-12-20 2021-06-24 Novozymes A/S Stabilized liquid boron-free enzyme compositions
WO2021123307A2 (en) 2019-12-20 2021-06-24 Novozymes A/S Polypeptides having proteolytic activity and use thereof
KR20220119607A (ko) 2019-12-20 2022-08-30 헨켈 아게 운트 코. 카게아아 디스페르신 ix를 포함하는 세정 조성물
WO2021122117A1 (en) 2019-12-20 2021-06-24 Henkel Ag & Co. Kgaa Cleaning composition coprising a dispersin and a carbohydrase
KR20220119609A (ko) 2019-12-20 2022-08-30 헨켈 아게 운트 코. 카게아아 디스페르신 vi을 포함하는 세정 조성물
WO2021151536A1 (en) 2020-01-29 2021-08-05 Unilever Ip Holdings B.V. Laundry detergent product
US12497606B2 (en) 2020-01-31 2025-12-16 Novozymes A/S Mannanase variants and polynucleotides encoding same
JP7731360B2 (ja) 2020-01-31 2025-08-29 ノボザイムス アクティーゼルスカブ マンナナーゼバリアント及びそれをコードするポリヌクレオチド
MX2022009968A (es) 2020-02-14 2022-09-19 Basf Se Variantes de mananasa.
EP3892708A1 (de) 2020-04-06 2021-10-13 Henkel AG & Co. KGaA Reinigungszusammensetzungen mit dispersinvarianten
US20230143128A1 (en) 2020-04-08 2023-05-11 Novozymes A/S Carbohydrate binding module variants
WO2021214059A1 (en) 2020-04-21 2021-10-28 Novozymes A/S Cleaning compositions comprising polypeptides having fructan degrading activity
EP3907271A1 (de) 2020-05-07 2021-11-10 Novozymes A/S Reinigungszusammensetzung, verwendung und verfahren zum reinigen
JP2023530443A (ja) 2020-06-18 2023-07-18 ビーエーエスエフ ソシエタス・ヨーロピア 組成物及びその使用
EP4172298A1 (de) 2020-06-24 2023-05-03 Novozymes A/S Verwendung von cellulasen zur entfernung von staubmilben aus textilien
EP3936593A1 (de) 2020-07-08 2022-01-12 Henkel AG & Co. KGaA Reinigungszusammensetzungen und verwendungen davon
JP7736383B2 (ja) 2020-07-09 2025-09-09 ベーアーエスエフ・エスエー 組成物及びその用途
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
WO2022023250A1 (en) 2020-07-27 2022-02-03 Unilever Ip Holdings B.V. Use of an enzyme and surfactant for inhibiting microorganisms
BR112023003468A2 (pt) 2020-08-25 2023-04-11 Novozymes As Variantes de uma xiloglucanase da família 44
US20230354850A1 (en) 2020-09-15 2023-11-09 Novozymes A/S Animal feed comprising insects or insect meal
CN116507725A (zh) 2020-10-07 2023-07-28 诺维信公司 α-淀粉酶变体
WO2022084303A2 (en) 2020-10-20 2022-04-28 Novozymes A/S Use of polypeptides having dnase activity
WO2022083949A1 (en) 2020-10-20 2022-04-28 Basf Se Compositions and their use
EP4237525A1 (de) 2020-10-28 2023-09-06 Novozymes A/S Verwendung von lipoxygenase
BR112023008326A2 (pt) 2020-10-29 2023-12-12 Novozymes As Variantes de lipase e composições compreendendo tais variantes de lipase
CN116670261A (zh) 2020-11-13 2023-08-29 诺维信公司 包含脂肪酶的洗涤剂组合物
WO2022106400A1 (en) 2020-11-18 2022-05-27 Novozymes A/S Combination of immunochemically different proteases
KR102559665B1 (ko) 2020-11-27 2023-07-26 류용근 실제 위치와 가상 위치의 매핑을 이용한 게임 서비스 제공 방법
CN112501149B (zh) * 2020-12-21 2022-03-18 天津科技大学 一种碱性蛋白酶突变体及其基因、工程菌、制备方法和应用
EP4032966A1 (de) 2021-01-22 2022-07-27 Novozymes A/S Flüssige enzymzusammensetzung mit sulfitabfänger
EP4284905A1 (de) 2021-01-28 2023-12-06 Novozymes A/S Lipase mit geringer geruchsbildung
EP4039806A1 (de) 2021-02-04 2022-08-10 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzung mit xanthan-lyase- und endoglucanase-varianten mit verbesserter stabilität
EP4291646A2 (de) 2021-02-12 2023-12-20 Novozymes A/S Alpha-amylase-varianten
CN117015592A (zh) 2021-02-12 2023-11-07 诺维信公司 稳定的生物洗涤剂
EP4305146A1 (de) 2021-03-12 2024-01-17 Novozymes A/S Polypeptidvarianten
US20240060061A1 (en) 2021-03-15 2024-02-22 Novozymes A/S Dnase variants
EP4060036A1 (de) 2021-03-15 2022-09-21 Novozymes A/S Polypeptidvarianten
US20240218300A1 (en) 2021-03-26 2024-07-04 Novozymes A/S Detergent composition with reduced polymer content
EP4359518A1 (de) 2021-06-23 2024-05-01 Novozymes A/S Alpha-amylase-polypeptide
US20240400945A1 (en) 2021-10-13 2024-12-05 Basf Se Compositions comprising polymers, polymers, and their use
WO2023066741A1 (en) 2021-10-20 2023-04-27 Basf Se Phosphate-free composition and methods for their manufacture and use
EP4437075B1 (de) 2021-11-22 2025-09-24 Basf Se Zusammensetzungen mit polymeren und deren verwendung
CN118284680A (zh) 2021-11-22 2024-07-02 巴斯夫欧洲公司 包含聚合物的组合物、聚合物及其用途
MX2024007407A (es) 2021-12-17 2024-07-04 Basf Se Composiciones y sus aplicaciones.
WO2023117962A1 (en) 2021-12-21 2023-06-29 Basf Se Chemical product passport
CN118871559A (zh) 2021-12-21 2024-10-29 诺维信公司 包含脂肪酶和加强剂的组合物
EP4206309A1 (de) 2021-12-30 2023-07-05 Novozymes A/S Proteinpartikel mit verbesserter weisse
EP4234664A1 (de) 2022-02-24 2023-08-30 Evonik Operations GmbH Zusammensetzung mit glucolipiden und enzymen
US20250179393A1 (en) 2022-03-02 2025-06-05 Novozymes A/S Use of xyloglucanase for improvement of sustainability of detergents
CA3242259A1 (en) 2022-03-04 2023-09-07 Novozymes A/S Dnase variants and compositions
CN118974228A (zh) 2022-04-08 2024-11-15 诺维信公司 氨基己糖苷酶变体和组合物
CN114540330B (zh) * 2022-04-21 2022-07-12 深圳润康生态环境股份有限公司 一种碱性蛋白酶突变体AprBpM及其应用
EP4532671B1 (de) 2022-06-03 2026-02-11 Unilever IP Holdings B.V. Waschmittelprodukt
WO2023247348A1 (en) 2022-06-21 2023-12-28 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP4544015A2 (de) 2022-06-24 2025-04-30 Novozymes A/S Lipasevarianten und zusammensetzungen mit solchen lipasevarianten
EP4555061A1 (de) 2022-07-15 2025-05-21 Basf Se Alkanolaminformiate zur enzymstabilisierung in flüssigen formulierungen
WO2024083589A1 (en) 2022-10-18 2024-04-25 Basf Se Detergent compositions, polymers and methods of manufacturing the same
CN121628881A (zh) * 2022-10-27 2026-03-10 青岛蔚蓝生物集团有限公司 高比活碱性蛋白酶突变体
CN121555480A (zh) * 2022-10-27 2026-02-24 青岛蔚蓝生物集团有限公司 一种耐高温碱性蛋白酶突变体及其应用
CN120225643A (zh) 2022-12-05 2025-06-27 诺维信公司 包含脂肪酶和肽的组合物
CN120265743A (zh) 2022-12-14 2025-07-04 诺维信公司 改善的脂肪酶（gcl1）变体
EP4389864A1 (de) 2022-12-20 2024-06-26 Basf Se Cutinasen
WO2024131880A2 (en) 2022-12-23 2024-06-27 Novozymes A/S Detergent composition comprising catalase and amylase
CN120435539A (zh) 2023-01-23 2025-08-05 诺维信公司 清洁组合物及其用途
WO2024194245A1 (en) 2023-03-21 2024-09-26 Novozymes A/S Detergent compositions based on biosurfactants
KR20250174069A (ko) 2023-04-12 2025-12-11 노보자임스 에이/에스 알칼리성 포스파타아제 활성을 갖는 폴리펩타이드를 포함하는 조성물
WO2024226828A2 (en) 2023-04-26 2024-10-31 Novozymes A/S Cleaning composition and cleaning method
EP4461796A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
EP4461795A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
EP4709830A1 (de) 2023-05-11 2026-03-18 Novozymes A/S Maschinengeschirrspülmittel enthaltend lipase
CN121358834A (zh) 2023-06-28 2026-01-16 诺维信公司 包含脂肪酶的洗涤剂组合物
CN121420051A (zh) 2023-07-07 2026-01-27 诺维信公司 用于去除蛋白质污渍的洗涤方法
CN121712874A (zh) 2023-08-15 2026-03-20 赢创运营有限公司 用于洗涤毛的生物表面活性剂
WO2025088003A1 (en) 2023-10-24 2025-05-01 Novozymes A/S Use of xyloglucanase for replacement of optical brightener
WO2025103765A1 (en) 2023-11-17 2025-05-22 Novozymes A/S Lytic polysaccharide monooxygenases and their use in detergent
WO2025114053A1 (en) 2023-11-30 2025-06-05 Novozymes A/S Biopolymers for use in detergent
WO2025132258A1 (en) 2023-12-20 2025-06-26 Basf Se Stabilized enzyme composition comprising a protease
EP4653801A1 (de) 2024-05-21 2025-11-26 Mole Moreschi S.r.l. Vorrichtung zum messen der materialabtragstiefe von einem objekt
WO2025257254A1 (en) 2024-06-12 2025-12-18 Novozymes A/S Lipases and lipase variants and the use thereof
WO2026017636A1 (en) 2024-07-17 2026-01-22 Novozymes A/S Compositions comprising combination of enzymes
WO2026046881A1 (en) 2024-08-26 2026-03-05 Novozymes A/S Compositions comprising a hexosaminidase and a protease

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340735A (en) * 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
US5665587A (en) * 1989-06-26 1997-09-09 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
US5700676A (en) * 1984-05-29 1997-12-23 Genencor International Inc. Modified subtilisins having amino acid alterations
US5741694A (en) * 1988-01-07 1998-04-21 Novo Nordisk A/S Useful mutations of bacterial alkaline protease
US6190900B1 (en) * 1995-05-05 2001-02-20 Novo Nordisk A/S Subtilase variants
US6287841B1 (en) * 1988-02-11 2001-09-11 Genencor International, Inc. High alkaline serine protease
US6300116B1 (en) * 1996-11-04 2001-10-09 Novozymes A/S Modified protease having improved autoproteolytic stability
US6312936B1 (en) * 1997-10-23 2001-11-06 Genencor International, Inc. Multiply-substituted protease variants
US6376450B1 (en) * 1998-10-23 2002-04-23 Chanchal Kumar Ghosh Cleaning compositions containing multiply-substituted protease variants
US6586224B1 (en) * 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
US6586223B1 (en) * 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6599730B1 (en) * 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
US20050054843A1 (en) * 2001-12-31 2005-03-10 Estell David A Proteases producing an altered immunological response and methods of making and using the same
US6893855B2 (en) * 2000-10-13 2005-05-17 Novozymes A/S Subtilase variants

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234445A (de) 1967-10-03 1971-06-03
GB1296839A (de) 1969-05-29 1972-11-22
GB1372034A (en) 1970-12-31 1974-10-30 Unilever Ltd Detergent compositions
GB1483591A (en) 1973-07-23 1977-08-24 Novo Industri As Process for coating water soluble or water dispersible particles by means of the fluid bed technique
GB1590432A (en) 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
DE2633601A1 (de) * 1976-07-27 1978-02-02 Henkel Kgaa Fluessiges, als wasch- und reinigungsmittel verwendbares, enzymhaltiges konzentrat
DK187280A (da) 1980-04-30 1981-10-31 Novo Industri As Ruhedsreducerende middel til et fuldvaskemiddel fuldvaskemiddel og fuldvaskemetode
DK263584D0 (da) 1984-05-29 1984-05-29 Novo Industri As Enzymholdige granulater anvendt som detergentadditiver
US5155033A (en) 1989-01-06 1992-10-13 Genencor, Inc. Subtilisins modified at position 225 resulting in a shift in catalytic activity
JPH0697997B2 (ja) 1985-08-09 1994-12-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ 新規の酵素的洗浄剤添加物
EG18543A (en) 1986-02-20 1993-07-30 Albright & Wilson Protected enzyme systems
DK160947C (da) 1986-04-17 1991-10-21 Novo Industri As Gen-udtrykkelsessystem
DE3750916T2 (de) * 1986-04-30 1995-06-01 Genencor Int Mutante einer nicht menschlichen Carbonyl-Hydrolase, für diese kodierende DNS-Sequenzen und Vektoren und durch diese Vektoren transformierte Wirte.
ATE110768T1 (de) 1986-08-29 1994-09-15 Novo Nordisk As Enzymhaltiger reinigungsmittelzusatz.
NZ221627A (en) 1986-09-09 1993-04-28 Genencor Inc Preparation of enzymes, modifications, catalytic triads to alter ratios or transesterification/hydrolysis ratios
DE3854249T2 (de) 1987-08-28 1996-02-29 Novonordisk As Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen.
EP0471265B1 (de) 1988-01-07 1995-10-25 Novo Nordisk A/S Spezifische Protease
CN1056187C (zh) * 1988-02-11 2000-09-06 金克克国际有限公司 新的蛋白水解酶及其在洗涤剂中的应用
US5324653A (en) * 1988-02-11 1994-06-28 Gist-Brocades N.V. Recombinant genetic means for the production of serine protease muteins
JP3079276B2 (ja) 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
WO1989009259A1 (en) 1988-03-24 1989-10-05 Novo-Nordisk A/S A cellulase preparation
US5776757A (en) 1988-03-24 1998-07-07 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof
EP0405902A1 (de) * 1989-06-26 1991-01-02 Unilever Plc Enzymatische Waschmittelzusammensetzungen
DK316989D0 (da) 1989-06-26 1989-06-26 Novo Nordisk As Enzymer
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
EP0528828B2 (de) 1990-04-14 1997-12-03 Genencor International GmbH Alkalische bacillus-lipasen, hierfür codierende dna-sequenzen sowie bacilli, die diese lipasen produzieren
CA2082279C (en) 1990-05-09 2007-09-04 Grethe Rasmussen Cellulase preparation comprising an endoglucanase enzyme
DK115890D0 (da) 1990-05-09 1990-05-09 Novo Nordisk As Enzym
DE69129988T2 (de) 1990-09-13 1999-03-18 Novo Nordisk A/S, Bagsvaerd Lipase-varianten
DE69133035T2 (de) 1991-01-16 2003-02-13 The Procter & Gamble Company, Cincinnati Kompakte Waschmittelzusammensetzungen mit hochaktiven Cellulasen
DK0583420T3 (da) 1991-04-30 1996-07-29 Procter & Gamble Builderholdige flydende detergenter med borsyre-polyol-kompleks til inhibering af proteolytisk enzym
EP0511456A1 (de) 1991-04-30 1992-11-04 The Procter & Gamble Company Flüssiges Reinigungsmittel mit einem aromatischen Boratester zur Inhibierung des proteolytischen Enzyms
KR100258460B1 (ko) 1991-05-01 2000-06-01 한센 핀 베네드 안정화 효소 및 세제 조성물
US5846802A (en) * 1992-04-15 1998-12-08 Buxton; Frank Fungal Protease
DK72992D0 (da) 1992-06-01 1992-06-01 Novo Nordisk As Enzym
DK88892D0 (da) 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
EP0651794B1 (de) 1992-07-23 2009-09-30 Novozymes A/S MUTIERTE -g(a)-AMYLASE, WASCHMITTEL UND GESCHIRRSPÜLMITTEL
EP1431389A3 (de) 1992-10-06 2004-06-30 Novozymes A/S Zellulase Variante
CZ293163B6 (cs) 1993-02-11 2004-02-18 Genencor International, Inc. Mutanta alfa-amylázy, její použití, kódová DNA pro tuto mutantu, vektor pro expresi, hostitelské buňky, čisticí prostředek a prostředek pro zkapalnění škrobu
ATE287946T1 (de) 1993-04-27 2005-02-15 Genencor Int Neuartige lipasevarianten zur verwendung in reinigungsmitteln
DK52393D0 (de) 1993-05-05 1993-05-05 Novo Nordisk As
JP2859520B2 (ja) 1993-08-30 1999-02-17 ノボ ノルディスク アクティーゼルスカブ リパーゼ及びそれを生産する微生物及びリパーゼ製造方法及びリパーゼ含有洗剤組成物
US6436690B1 (en) 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
EP0724631A1 (de) 1993-10-13 1996-08-07 Novo Nordisk A/S H 2?o 2?-stabile peroxidasevarianten
MA23346A1 (fr) 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
JPH07143883A (ja) 1993-11-24 1995-06-06 Showa Denko Kk リパーゼ遺伝子及び変異体リパーゼ
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
EP0746618B1 (de) 1994-02-22 2002-08-21 Novozymes A/S Methode zur herstellung einer variante eines lipolytischen enzymes
WO1995024471A1 (en) 1994-03-08 1995-09-14 Novo Nordisk A/S Novel alkaline cellulases
JP3851656B2 (ja) 1994-05-04 2006-11-29 ジェネンコア インターナショナル インコーポレーテッド 改善された界面活性剤耐性を有するリパーゼ
WO1995035381A1 (en) 1994-06-20 1995-12-28 Unilever N.V. Modified pseudomonas lipases and their use
WO1996000292A1 (en) 1994-06-23 1996-01-04 Unilever N.V. Modified pseudomonas lipases and their use
DE69535733T2 (de) 1994-10-06 2009-04-23 Novozymes A/S Ein enzympräparat mit endoglucanase aktivität
BE1008998A3 (fr) 1994-10-14 1996-10-01 Solvay Lipase, microorganisme la produisant, procede de preparation de cette lipase et utilisations de celle-ci.
BR9509525A (pt) 1994-10-26 1995-10-26 Novo Nordisk As Construção de dna vetor de expressão recombinante célula processo para produzir a enzima que exibe atividade lipolítica enzima que exibe atividade lipolítica preparação de enzima aditivo de detergente e composição de detergente
AR000862A1 (es) 1995-02-03 1997-08-06 Novozymes As Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del
JPH08228778A (ja) 1995-02-27 1996-09-10 Showa Denko Kk 新規なリパーゼ遺伝子及びそれを用いたリパーゼの製造方法
IL117350A0 (en) 1995-03-09 1996-07-23 Procter & Gamble Proteinase k variants having decreased adsorption and increased hydrolysis
EP0815209B2 (de) 1995-03-17 2015-02-25 Novozymes A/S Neue endoglukanase
ATE429490T1 (de) 1995-05-05 2009-05-15 Novozymes As Protease-varianten und verbindungen
WO1997007202A1 (en) 1995-08-11 1997-02-27 Novo Nordisk A/S Novel lipolytic enzymes
AU6414196A (en) 1995-07-14 1997-02-18 Novo Nordisk A/S A modified enzyme with lipolytic activity
US5763385A (en) 1996-05-14 1998-06-09 Genencor International, Inc. Modified α-amylases having altered calcium binding properties
US5928706A (en) 1996-08-09 1999-07-27 Gibson; Suzanne M. Heat-stable protein microparticles and no-shear process for producing same
AU3938997A (en) 1996-08-26 1998-03-19 Novo Nordisk A/S A novel endoglucanase
BR9711479B1 (pt) 1996-09-17 2009-08-11 variante de celulase tendo uma resistência aumentada a tensìdeo de ánion.
CA2265734A1 (en) 1996-10-08 1998-04-16 Novo Nordisk A/S Diaminobenzoic acid derivatives as dye precursors
BR9712473B1 (pt) 1996-11-04 2009-08-11 variantes de subtilase e composições.
WO1998034946A1 (en) 1997-02-12 1998-08-13 Massachusetts Institute Of Technology Daxx, a novel fas-binding protein that activates jnk and apoptosis
AU7908898A (en) 1997-07-04 1999-01-25 Novo Nordisk A/S Family 6 endo-1,4-beta-glucanase variants and cleaning composit ions containing them
AU1225099A (en) 1997-11-21 1999-06-15 Novo Nordisk A/S Protease variants and compositions
US6773907B2 (en) * 1997-11-21 2004-08-10 Peter Kamp Hansen Subtilase enzymes
US6831053B1 (en) * 1998-10-23 2004-12-14 The Procter & Gamble Company Bleaching compositions comprising multiply-substituted protease variants
CA2394971C (en) * 1999-12-15 2016-01-19 Novozymes A/S Subtilase variants having an improved wash performance on egg stains
JP2004508011A (ja) * 2000-04-03 2004-03-18 マキシジェン，　インコーポレイテッド スブチリシン変異体
EP2258835A1 (de) * 2000-04-28 2010-12-08 Novozymes A/S Variante eines lipolytischen Enzyms
MXPA03007316A (es) * 2001-02-19 2003-12-04 Merck Patent Gmbh Metodo para la identificacion de epitopes de celulas t y el uso para la preparacion de moleculas con inmunogenicidad reducida.
DK200101090A (da) * 2001-07-12 2001-08-16 Novozymes As Subtilase variants
US7332320B2 (en) * 2001-12-31 2008-02-19 Genencor International, Inc. Protease producing an altered immunogenic response and methods of making and using the same
ATE450606T1 (de) * 2002-01-16 2009-12-15 Genencor Int Mehrfachsubstituierte proteasevarianten
WO2004003186A2 (en) * 2002-06-26 2004-01-08 Novozymes A/S Subtilases and subtilase variants having altered immunogenicity
US7888093B2 (en) * 2002-11-06 2011-02-15 Novozymes A/S Subtilase variants
US7477636B2 (en) 2003-11-26 2009-01-13 Agere Systems Inc. Processor with scheduler architecture supporting multiple distinct scheduling algorithms
US20070161531A1 (en) * 2005-07-08 2007-07-12 Novozymes A/S Subtilase variants

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700676A (en) * 1984-05-29 1997-12-23 Genencor International Inc. Modified subtilisins having amino acid alterations
US5741694A (en) * 1988-01-07 1998-04-21 Novo Nordisk A/S Useful mutations of bacterial alkaline protease
US6808913B2 (en) * 1988-01-07 2004-10-26 Novozymes A/S Useful mutations of bacterial alkaline protease
US6287841B1 (en) * 1988-02-11 2001-09-11 Genencor International, Inc. High alkaline serine protease
US5665587A (en) * 1989-06-26 1997-09-09 Novo Nordisk A/S Modified subtilisins and detergent compositions containing same
US5340735A (en) * 1991-05-29 1994-08-23 Cognis, Inc. Bacillus lentus alkaline protease variants with increased stability
US6599730B1 (en) * 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
US6190900B1 (en) * 1995-05-05 2001-02-20 Novo Nordisk A/S Subtilase variants
US6300116B1 (en) * 1996-11-04 2001-10-09 Novozymes A/S Modified protease having improved autoproteolytic stability
US6815193B2 (en) * 1997-10-23 2004-11-09 Genencor International, Inc. Multiply-substituted protease variants
US6482628B1 (en) * 1997-10-23 2002-11-19 Genencor International, Inc. Multiply-substituted protease variants
US6673590B1 (en) * 1997-10-23 2004-01-06 Genencor International, Inc. Multiply-substituted protease variants with altered net charge for use in detergents
US6312936B1 (en) * 1997-10-23 2001-11-06 Genencor International, Inc. Multiply-substituted protease variants
US6927055B2 (en) * 1997-10-23 2005-08-09 Genencor International, Inc. Multiply-substituted protease variants
US6376450B1 (en) * 1998-10-23 2002-04-23 Chanchal Kumar Ghosh Cleaning compositions containing multiply-substituted protease variants
US6586224B1 (en) * 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
US6586223B1 (en) * 1999-07-22 2003-07-01 The Procter & Gamble Company Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6610642B2 (en) * 2000-04-20 2003-08-26 The Procter And Gamble Company Cleaning compositions containing multiply-substituted protease variants
US6838425B2 (en) * 2000-04-20 2005-01-04 The Procter & Gamble Company Cleaning compositions containing multiply-substituted protease variants
US6893855B2 (en) * 2000-10-13 2005-05-17 Novozymes A/S Subtilase variants
US20050054843A1 (en) * 2001-12-31 2005-03-10 Estell David A Proteases producing an altered immunological response and methods of making and using the same

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050003986A1 (en) * 1988-01-07 2005-01-06 Novozymes A/S Useful mutations of bacterial alkaline protease
US7605115B2 (en) * 2000-04-03 2009-10-20 Novozymas Als Subtilisin variants
US20070270574A1 (en) * 2000-04-03 2007-11-22 Novozymes A/S Subtilisin variants
US9732310B2 (en) 2002-11-06 2017-08-15 Novozymes A/S Subtilase variants
US20070015677A1 (en) * 2003-05-07 2007-01-18 Novozymes A/S Variant subtilising enzymes (subtilases)
US7507569B2 (en) * 2003-05-07 2009-03-24 Novozymes A/S Variant subtilisin enzymes (subtilases)
WO2006064721A1 (ja) * 2004-12-13 2006-06-22 The New Industry Research Organization 低温活性型サチライシン
US9133423B2 (en) 2005-07-08 2015-09-15 Novozymes A/S Subtilase variants
US20100120091A1 (en) * 2005-07-08 2010-05-13 Novozymes A/S Subtilase variants
US20070161531A1 (en) * 2005-07-08 2007-07-12 Novozymes A/S Subtilase variants
WO2009021867A3 (de) * 2007-08-10 2009-04-02 Henkel Ag & Co Kgaa Mittel enthaltend proteasen
WO2018118917A1 (en) * 2016-12-21 2018-06-28 Danisco Us Inc. Protease variants and uses thereof
EP4520820A3 (de) * 2016-12-21 2025-04-16 Danisco Us Inc Proteasevarianten und verwendungen davon
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Also Published As

Publication number Publication date
US10351837B2 (en) 2019-07-16
JP2004537994A (ja) 2004-12-24
US20140018283A1 (en) 2014-01-16
NZ541095A (en) 2008-02-29
US20170096654A1 (en) 2017-04-06
EP1409659B1 (de) 2008-10-01
DE60229136D1 (de) 2008-11-13
US20150024990A1 (en) 2015-01-22
US20110152155A1 (en) 2011-06-23
NZ530237A (en) 2006-05-26
AU2002316816A1 (en) 2003-01-29
ZA200309666B (en) 2004-08-03
DK200101090A (da) 2001-08-16
US9528100B2 (en) 2016-12-27
ATE409744T1 (de) 2008-10-15
US20080167213A1 (en) 2008-07-10
EP1409659A2 (de) 2004-04-21
WO2003006602A3 (en) 2003-11-06
WO2003006602A2 (en) 2003-01-23
JP4383858B2 (ja) 2009-12-16
CN1537163A (zh) 2004-10-13
US8569035B2 (en) 2013-10-29
US20130225466A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
US10351837B2 (en) Subtilase variants
EP1244779B1 (de) Subtilasevarianten mit verbesserter waschleistung bei eierflecken
EP1141205B1 (de) Subtilasen der i-s1 und i-s2 untergruppen mit einem zusätzlichen aminosäurerest in der aktiven seitenschleifenregion
US6773907B2 (en) Subtilase enzymes
US6893855B2 (en) Subtilase variants
EP1183343B2 (de) Subtilase-enzyme der i-s1 und i-s2 untergruppen mit wenigstens einem zusätzlichen aminosäurerest zwischen positionen 125 und 126
EP1326966B2 (de) Subtilase varianten
EP1183335B2 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 130 und 131
EP1141257B1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen, mit einem zusätzlichen aminosäurerest in einer aktiven schleifenregion
EP1141258B1 (de) SUBTILASE ENZYME DER I-S1 und I-S2 UNTERGRUPPEN MIT EINEM ZUSÄTZLICHEN AMINOSAÜREREST IN EINER AKTIVEN SCHLEIFENREGION
EP1183342B1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 128 und 129
EP1183339B1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 129 und 130
EP1183340B1 (de) Subtilase-enzyme der i-s1 und i-s2 untergruppen mit wenigstens einem zusätzlichen aminosäurerest zwischen positionen 126 und 127
EP1183337B1 (de) SUBTILASE ENZYME DER I-S1 UND I-S2 UNTERGRUPPEN MIT MINDESTENS EINER ZUSäTZLICHEN AMINOSäURE ZWISCHEN POSITION 132 UND 133
EP1183336B2 (de) Subtilase-enzyme der i-s1 und i-s2 untergruppen mit wenigstens einem zusätzlichen aminosäurenrest zwischen position 131 und 132
EP1183341B2 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 127 und 128
EP1141259B1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen, mit einem zusätzlichen aminosäurenrest in einer aktiven schleifenregion
EP1803817B1 (de) Subtilase Enzyme der I-S1- und I-S2-Untergruppen mit einem zusätzlichen Aminosäurerest in einer aktiven Schleifenregion

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVOZYMES A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NANO, TINA SEJERSGAARD;VON DER OSTEN, CLAUS;KRUGER, MALENE KAPPEN;AND OTHERS;REEL/FRAME:015431/0787;SIGNING DATES FROM 20031016 TO 20031210

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION